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Abstract 
Several diseases are associated with perturbations in redox signaling and aberrant hydrogen 
sulfide metabolism, and numerous analytical methods exist for the measurement of the 
sulfur-containing species affected. However, uncertainty remains about their concentrations 
and speciation in cells/biofluids, perhaps in part due to differences in sample processing and 
detection principles. Using ultrahigh-performance liquid chromatography in combination with 
electrospray-ionization tandem mass spectrometry we here outline a specific and sensitive 
platform for the simultaneous measurement of 12 analytes, including total and free thiols, 
their disulfides and sulfide in complex biological matrices such as blood, saliva and urine. 
Total assay run time is <10 min, enabling high-throughput analysis. Enhanced sensitivity and 
avoidance of artifactual thiol oxidation is achieved by taking advantage of the rapid reaction 
of sulfhydryl groups with N-ethylmaleimide. We optimized the analytical procedure for 
detection and separation conditions, linearity, and precision including three stable isotope 
labelled standards. Its versatility for future more comprehensive coverage of the thiol redox 
metabolome was demonstrated by implementing additional analytes such as methanethiol, 
N-acetylcysteine, and coenzyme A.  Apparent plasma sulfide concentrations were found to 
vary substantially with sample pretreatment and nature of the alkylating agent. In addition to 
protein binding in the form of mixed disulfides (S-thiolation) a significant fraction of 
aminothiols and sulfide appears to be also non-covalently associated with proteins. 
Methodological accuracy was tested by comparing the plasma redox status of 10 healthy 
human volunteers to a well-established protocol optimized for reduced/oxidized glutathione. 
In a proof-of-principle study a deeper analysis of the thiol redox metabolome including free 
reduced/oxidized as well as bound thiols and sulfide was performed. Additional determination 
of acid-labile sulfide/thiols was demonstrated in human blood cells, urine and saliva. Using 
this simplified mass spectrometry-based workflow the thiol redox metabolome can be 
determined in samples from clinical and translational studies, providing a novel 
prognostic/diagnostic platform for patient stratification, drug monitoring, and identification of 
new therapeutic approaches in redox diseases. 
 
Key words:  oxidative stress, redox status, reactive species interactome, glutathione, 
hydrogen sulfide, persulfides, thiol-maleimide michael addition.  
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Highlights 
 The thiol redox metabolome comprises free and bound thiols, disulfides, and sulfide 
 We developed a LC-MS/MS platform for detection of the thiol redox metabolome in 
biological samples 
 Thiols in blood, urine and saliva are stabilized by derivatization with N-
ethylmaleimide, also preventing oxidation 
 Total and acid-labile thiols are determined following addition of DTT and acid 
 Accuracy was investigated by comparison with an established method to assess GSH 
and GSSG  
 Applicability was shown for plasma of 10 healthy volunteers, blood cells, urine and 
saliva  
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1  Introduction 
Many biological processes that have previously been associated with an overproduction of 
reactive oxygen species (ROS) and/or an impaired antioxidant and free radical scavenging 
capacity were thought to culminate in ‘oxidative stress’, cell death and tissue damage. More 
recently, such conditions are interpreted to reflect situations in which a shift in redox poise 
has occurred, affecting both global and regional redox status and cysteine-based redox 
signalling [1-3]. Importantly, unfavorable outcomes may not be inevitable if intervened early 
on. Consequently, there is an increased interest in analytical methods that provide a more 
refined mapping of the associated metabolic changes and enable further study of the 
underlying mechanisms.  
In parallel with those developments, there has been a resurgence of interest in the biological 
effects of hydrogen sulfide (H2S)
1 and related oxidation products such as persulfides and 
polysulfides [4-6]. No specific biological targets have yet been identified for those 
compounds, and many of their effects appear to be mediated by interaction with metals, 
heme proteins or redox interaction with other sulfur species. Moreover, sulfide is involved in 
post-translational protein modification (persulfidation, S-sulfhydration) whereby reactive 
cysteine groups involved in redox signaling are modified, resulting in altered chemical 
reactivity and protein function [7].  
Interestingly, ROS were shown to chemically and functionally interact with nitric oxide (NO) 
and other reactive nitrogen species (RNS), as well as with sulfide-related reactive sulfur 
species (RSS) such as thiyl radicals, persulfides and polysulfides. Our group recently 
proposed that the interaction of ROS, RNS and RSS with each other and with their thiol 
targets constitute a ‘reactive species interactome’ (RSI) that regulates fundamental cellular 
processes involved in stress signaling [3]. The RSI enables single cells and whole organisms 
to sense and adapt to alterations in nutritional, metabolic and environmental conditions [3]. A 
corollary of this concept is that assesement of only a few constituents of this RSI as “markers 
of oxidative stress” (e.g. oxidized lipids) will not be sufficient to provide useful insight as they 
cannot adequately capture the complexity of the chemical interactions within the RSI. This 
may explain why the redox community has been struggling in successfully identifying the key 
regulatory nodes and operating principles of this interaction network, and to e.g. understand 
how specific thiols and redox switches like the nuclear factor erythroid 2 [NF-E2]-related 
factor 2 (Nrf2) contribute to redox homeostais in health and disease. Thus, the renewed 
interest in sulfide related phenomena, antioxidant processes and redox signaling demands 
                                                
1
 Hydrogen sulfide (H2S) in aqueous solution undergoes rapid ionization and is mainly found in the 
form of HS
-
 with negligile amounts of S2
-
 at pH 7.4. For simplicity, the sum of all three species are 
referred to as „sulfide“ hereinafter. 
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quantification of pertinent redox-regulated events in much higher resolution than hitherto 
accomplished.  
Given that glutathione is the major intracellular low-molecular-weight (LMW) aminothiol, 
much of the earlier ‘oxidative stress’ literature revolved around pathways of formation and 
degradation of this ubiquitous and (according to Helmut Sies) “inevitable” antioxidant [8], 
besides the measurement of protein, lipid and DNA oxidation products as biomarkers of an 
increased oxidative burden. As a result, many different methods have been developed to 
quantify glutathione and related metabolites in blood and tissues [9-12], and the ratio of 
reduced over oxidized glutathione (GSH/GSSG) has been used for decades as a sensitive 
oxidative stress biomarker [11, 13, 14]. In many of these methods the sulfhydryl (-SH) group 
of the aminothiol is derivatized with an electrophile such as monobromobimane (mBB), 
iodoacetic acid (IAA), iodoacetamide (IAM) or N-ethylmaleimide (NEM). This reaction step 
serves two purposes: i) it prevents ambient air mediated oxidation of the thiols to their 
corresponding disulfides [10, 15] and ii) it conveniently forms a fluorescent product [16], often 
improving sensitivity limits for detection.  
More recently, the cysteine/cystine (Cys/CysSS) redox couple emerged, along with 
GSH/GSSG, as a powerful predictor of cardiovascular mortality [17]. Circulating total 
homocysteine has been used as an integrative biomarker of folate and methionine 
metabolism, cobalamine deficiency and cardiometabolic risk for some time [18], while the 
mixture of “free thiols” and “protein-bound thiols” (including glutathione, cysteine, and 
homocysteine; please refer to Box 1 for definitions of terms in italics) was proposed to reflect 
the plasma redox thiol status more than 2 decades ago [19, 20]. Most of the methods used to 
determine these species employ either high pressure liquid chromatography (HPLC) or a 
similar chromatographic separation technique coupled to a ultraviolet, fluorescence or 
electrochemical detector. In more recent applications these detectors have been replaced by 
mass spectrometers, potentially offering more specific and sensitive measurements [21, 22].  
There is accumulating evidence that these mesurements may be applied in clinical settings 
to predict morbidity and mortality from redox diseases [3]. Interestingly, even the rather 
simple spectrophotometric measurement of total free thiol availability using a non-selective 
free sulfhydryl probe (Ellman’s reagent) in plasma or serum has been demonstrated to have 
an astonishing power to predict graft failure and mortality in renal transplant patients and 
cardiovascular mortality in a heart failure cohort [23, 24]. This suggests that the single free 
SH group of circulating serum albumin may be another integrative biomarker of redox-
sensitive events in vivo [3]. S-cysteinylated or and S-glutathionylated albumin have also been 
proposed to represent useful biomarkers of oxidative stress [25, 26], and albumin itself may 
be an important transporter of low-molecular weight thiols by allowing the formation of 
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reversible mixed disulfides. The complexity of the methionine recycling, transsulfuration and 
glutathione metabolic pathways suggests that no single biomarker will adequately capture 
overall metabolic and redox status of all of these pathways at a global level.   
Many different assays for the quantification of sulfide in seawater or simple aqueous buffer 
systems exist, but not all are suited for the detection of sulfide in biological material [27, 28]. 
Modifications of a century-old colorimetric technique, the methylene blue assay [29, 30], 
have been used by many research groups to detect sulfide in blood, and reports from several 
groups hinted at associations between blood pressure or metabolic status and methylene 
blue reactive material (interpreted to reflect sulfide levels). While the overall specificity of the 
methylene blue assay for sulfur and its low running costs continue to contribute to its 
popularity, doubts have been raised as to its reliability for the quantification of sulfide in 
complex biological media [31]. In the last couple of years a large number of fluorimetric 
probes have been developed to detect sulfide [32], but many retain some cross-reactivity 
with other RSS. Moreover, an HPLC-based method with fluorimetric detection that employs 
the reaction of sulfide with mBB has been developed [33-35] and is now widely used for 
sulfide quantification in biological material. Most recently, the same reaction principle was 
exploited to develop a more specific detection technique for sulfide using liquid 
chromatography hyphenated to tandem mass spectrometry [36].  
In spite of all these developments, still relatively little is known about specific pathways of 
sulfide metabolism (other than its oxidation to thiosulfate and sulfate) in humans, and/or how 
changes in circulating sulfide concentrations relate to plasma thiol redox status. Some of the 
electrophilic compounds used to derivatise aminothiols before chromatographic separation 
such as mBB [16] and NEM [37, 38] are known to also react with sulfide. Surprisingly, this 
potential does not yet seem to have been exploited in more recent approaches using mass 
spectrometry to measure aminothiol concentrations together with sulfide. 
The aim of the present study was to describe the development of an analytical platform that 
allows simultaneous determination of the thiol redox metabolome, including total and free 
thiols, and their corresponding disulfides as well as sulfide in complex biological matrices 
such as human blood, saliva and urine. We here present first proof-of-concept results of our 
own method development using NEM as alkylating agent for thiols and sulfide to achieve this 
objective, and discuss advantages, pitfalls and limitations. 
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2 Materials and Methods  
2.1 Chemicals and reagents 
Unless otherwise stated all reagents and materials were of the highest purity available and 
purchased from Sigma-Aldrich (Gillingham, UK or Munich, Germany). Dual stable isotope 
(13C, 15N) labelled reduced (GSH) and oxidized glutathione (GSSG) were from Cambridge 
Isotopes and obtained from CK Isotopes Ltd (Newtown Unthank, UK), N-ethyl-d5-maleimide 
(d5-NEM) was from Sigma-Aldrich. Sodium persulfide (Na2S2) was from Dojindo Europe 
(Neuss, Germany). Hanks´ balanced salt solution + Ca2+ + Mg2+ (HBSS+) was obtained from 
Invitrogen, bovine serum albumin (BSA) from Carl Roth (Karlsruhe, Germany) and HPLC-
grade solvents from either VWR (Darmstadt, Germany) or Fisher Scientific (UK). Argon gas 
(>99.99%) was from BOC Group (Guildford, UK). Ultrapure N2 gas was produced by a 
nitrogen generator (Parker Balston, UK). 
2.2 Human participants 
Blood was taken from healthy volunteers of either gender (20-58 years old) with informed 
consent to participate before enrollment. Procedures were approved by the ethics 
committees of the Heirich Heine University of Dusseldorf (ClinicalTrials.gov Identifier: 
NCT02272530) and the University of Southhampton (ERGO 30507/31426) and conducted in 
accordance with the Declaration of Helsinki.  
2.3 Instrumentation and chromatography 
The chromatography system used in most of the studies described was a Waters Aquity 
ultrahigh performance liquid chromatography (UPLC) system with a thermostatted 
autosampler (kept at 5°C) and an ultrahigh performance binary pump, coupled to a triple-
quadrupole mass spectrometer (Xevo TQ-S, Waters) equipped with a heated electrospray 
ionization source (ESI).  
Chromatographic separation of the target analytes was achieved using a 1.6 m Modus 100 
x 2.1 mm Aqua UPLC column (Chromatography Direct, Runcorn, UK) kept at a temperature 
of 30°C; mobile phase A was H2O with 0.15 % formic acid and 5 mM ammonium formate and 
mobile phase B was 95% acetonitrile with 5% H2O, 0.15% formic acid and 5 mM ammonium 
formate. The chromatographic gradient starts at 99% A, decreasing to 60% A over 4.5 min, 
before dropping to 0% A over 0.5 min and being held at at that level for 1.5 min. The column 
is brought back up to 99% mobile phase A over 0.5 min and held at 99% for a further 1 min 
to equilibrate. A flow rate of 0.2 ml/min was used throughout, and total run time including 
equilibration was 8 min. An injection volume of 5 l was used, with a wash step every ten 
injections consisting of 100% mobile phase B for 5 min, followed by a blank using the regular 
8 
 
gradient to control for potential carry-over and column equilibration. We found that carry-over 
was negligible with two needle rinse steps (300 µl methanol, followed by 600 µl H2O 
/acetonitrile 90/10%, v/v) between injections. 
Our initial separation attempts used an Aquity UPLC CSH C18 (1.7 m) 2.1 x 100 mm column 
(Waters) kept at 30°C; mobile phase A was H2O with 5 mM ammonium formate and mobile 
phase B was 95% acetonitrile with 5% H2O and 5 mM ammonium formate. The 
chromatographic gradient started at 95% A, decreasing to 40% A over 5 min before returning 
to 95% A over 1 min and being held at that level for a further 1 min, resulting in a total run 
time of 7 min at a constant flow rate of 0.2 ml/min. Experimental results depicted in Fig. 3 
and some panels of Fig. 4 were obtained using these separation conditions, as indicated in 
the figure legend. 
Mass spectrometry settings were as follows: capillary voltage 2.80 kV, source offset 6 V, 
desolvation gas flow 800 L/h, cone gas flow 150 L/h, nebuliser pressure 7.0 bar, collision gas 
(argon) flow 0.14 ml/min, desolvation temperature 250°C.  All analytes were detected using 
positive ionization in multiple reaction monitoring (MRM) mode with specific 
precursor/product ion combinations identified and cone and collision energies optimized for 
each individual compound during direct infusion of authentic standards. For this, compounds 
were dissolved in NEM-containing buffer at a concentration of approx. 1 µM and diluted in 
water containing 5 mM ammonium formate. In positive ionization mode the precursor 
(parent) compound is usually the protonated form of the starting material, and the 
fragmentation profile is dependent on the cone and collision energies applied; optimal 
detection parameters for these were established separately for each compound during direct 
infusion of authentic standards by varying those parameters and selecting the most suitable 
product (daughter) ion by intensity and specificity. In order to maximise sensitivity, accuracy 
and selectivity specific MRM time windows were used to minimise the number of concurrent 
MRM transitions being monitored. For quantification purposes the MRM transitions were 
therefore only monitored during the time window where the relevant compounds elute. For 
specifics including the chemical structures of analytes and m/z values of precursor>product 
couples monitored see Table 1. Signals were captured and data processed using MassLynx 
v.4.0 and Quanlynx v.4.0 software (Waters). 
2.4 Quantification 
Quantification of the compounds of interest was accomplished by comparison of peak areas 
to external standards with variations in ionization efficiency (and potential loss during 
ultrafiltration) adjusted using stable isotope labelled internal standards. Each class of 
compound, i.e. oxidized thiol, reduced thiol and sulfide-related species, has a representative 
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internal standard. For the oxidised thiols, 13C4
15N2-GSSG was used; for the reduced thiols 
13C2
15N-GSH was derivatized with an excess of NEM and used as internal standard. For 
sulfide, a deuterated stable-isotope labelled standard (32S-(d5-NEM)2) was prepared by 
reacting an exact amount of d5-NEM with a two-fold molar excess of Na2S in ammonium 
phosphate buffer pH 7.4 for 30 min at RT, and removing excess sulfide by bubbling for 60 
min with high-purity argon. A mixed internal standard working solution was prepared by 
combining all three stable-isotope labelled compounds in ammonium phosphate buffer pH 
7.4. Specific MRM conditions were established to monitor each of the internal standards 
(Table 1), and the ratio between the signal intensity of each analyte and its corresponding 
internal standard was used for quantification. Stock solutions of standards containing each 
analyte of interest were prepared fresh for each analysis in pH 7.4 ammonium phosphate 
buffer (except for cystine and homocysteine, which were prepared in 0.1 N HCl, while sulfide, 
persufide and methanethiol which were first dissolved in water) and serially diluted in buffer 
to construct a concentration response curve for calibration; each concentration of standard 
was spiked with the same final concentration of stable isotope standards.   
2.5 Derivatization of thiols and sulfide with NEM 
Preliminary LC-MS/MS experiments carried out with mixed thiol standards at room 
temperature (RT) and pH 7.4 revealed that the reaction with NEM was complete for all 
analytes in under 10 min. Those results were confirmed by spectrophotometric monitoring of 
NEM consumption under the same conditions (302 nm; Cary 60 UV/vis spectrophotometer), 
demonstrating rapid kinetics for the reactions of NEM with GSH, cysteine (Cys) and 
homocysteine (Hcys) (at a 1:1 molar ratio, reactions were complete within 12-15 seconds) 
whereas the reaction between NEM with sulfide (2:1 molar ratio) required 10 min for running 
to completion. Optimal pH was assessed by comparing reactions of NEM with either 
aqueous standards of select thiols (GSH, Cys, HCys, Sulfide and stable-isotope labelled 
GSH) or by addition of NEM stocks prepared at different pH to human plasma. For those 
experiments, 100 mM NEM stock solutions were prepared in different ammonium phosphate 
buffers adjusted to pH 6.0, 7.4, 8.0 and 9.0 and used within 5 min of preparation. Freshly 
aqueous solutions of thiols were individually reacted with NEM at these different pH values at 
a final concentration of 10 mM NEM, and after 5 min waiting aliquots of these NEM-thiol 
incubates were combined and analysed immediately. Endogenous thiols contained in human 
plasma (obtained by centrifugation of EDTA blood using the rapid centrifugation protocol as 
detailed in section 2.7) were derivatized using freshly prepared NEM stock solutions of 
different pH at a 1:10 v:v ratio (10 mM NEM final).  
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2.6 Assay validation 
Careful assay validation for linearity, over a range of biologically relevant concentrations, and 
a preliminary assessment of precision, reproducibility and limits of detection were carried out 
using authentic standards, according to standard procedures, and are shown in Tab. 1 and 
Fig. 1. Full validation awaits further assay refinement with inclusion of additional analytes of 
interest. 
2.7 Sample collection and storage 
Venous blood was collected from healthy human volunteers using a 21-gauge 
(0.80mmx19mm) butterfly needle and BD VacutainerTM tubes. Following gentle mixing by 
inversion, blood was processed immediately as described below. Saliva was collected using 
oral swabs (SalivetteTM, Salimetrics, Carlsbad, CA, USA) followed by centrifugation; a mid-
stream urine sample was collected using a sterile urine container. Sample aliquots were 
measured either fresh or transferred into cryovials (Nunc), snap frozen in liquid nitrogen and 
stored at -80°C until analysis. 
2.8 Sample preparation procedure and optimization 
For human plasma analysis, whole blood was collected directly into EDTA BD vacutainerTM 
tubes and gently mixed by repeated inversion; 1 volume (vol) of NEM (100 mM stock solution 
in PBS) was added to 9 vol of blood within 1 min, resulting in a final conc of 10 mM NEM 
(1:10 dilution), again followed by gentle mixing. Stabilized, anticoagulated blood was then 
centrifuged for 1 min at 3000 x g to separate plasma from cellular components, snap frozen 
in liquid nitrogen and kept at -80°C until analysis. Before analysis, NEM-derivatized plasma 
samples were then supplemented with the internal standard (dual stable-isotope labelled 
GSSG and NEM-derivatized GSH as well as d5-NEM-derivatized sulfide in ammonium 
phosphate buffer, 1:1 v/v; target concentrations 100 nM GSH, 200 nM GSSG, 100 nM 
sulfide), and afterwards samples were cleared by ultrafiltration using spin columns with a 10 
kD cut-off (Millipore).  
Each step of the sample preparation was carefully optimized and validated. To compare 
detection of thiols and sulfide in plasma with that in serum, whole blood was also collected 
into serum BD vacutainers, incubated for 60 min at RT to allow clotting, and then centrifuged 
at 3,000 x g according to the manufacturer’s protocol. To test the effects of other 
anticoagulants, whole blood was collected into BD vacutainers containg EDTA, heparin or 
citrate, diluted 9:1 with NEM (final NEM concentration 10 mM), centrifuged at 800 x g for 10 
min at 4°C (see Fig. 2). Centrifugation speed was optimized by comparing GSH levels in 
plasma obtained by standard/low-speed centrifugation of whole blood (800 x g, 10 min, 4°C) 
with short/high-speed centrifugation (1 min 3000 x g or 3 min 3000 x g at 4°C). Hemolysis 
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was excluded by assessing plasma free hemoglobin concentration by UV-visible 
spectroscopy [39]. Sample stability and stabilization conditions were determined by focussing 
primarily on the levels of GSH, GSSG and sulfide (although other thiols were assessed in 
parallel) when comparing the addition of different concentrations of NEM (1, 5, 10, 20 mM 
final concentration) to whole blood, or when NEM addition was delayed by specified periods 
of time (30 s; 5, 10, 15 and 20 min). To test the effects of time of addition of NEM in whole 
blood, and also the effects of freeze/thawing on stabilized samples, the same blood sample 
was divided into identical aliquots, which all underwent the indicated procedures (addition of 
NEM in whole blood or plasma, repeated freeze/thawing, etc,).  
2.9 Bound thiols, total thiols and acid-labile sulfide 
To determine the concentration of total thiols, free thiols and bound-thiols  (see Box 1), NEM 
stabilized plasma was divided into two aliquots: (a) to assess total thiols (= free thiols + 
bound thiols) one aliquot was treated with 50 mM dithiothreitol (DTT) for 30 min, which 
reduces LMW disulfides and mixed disulfides with proteins; (b) to determine free thiols one 
aliquot was left untreated. In both aliquots  thiol concentrations were assessed following 
NEM derivatization by LC-MS/MS analysis, as indicated above. Bound thiols were calculated 
by subtracting free thiols from total thiols. The same procedure was carried out with the blood 
cell pellet (comprising red blood cells (RBCs), white blood cells, and platelets), urine and 
saliva samples, except that incubation time with DTT for urine and saliva was only 10 min.   
Optimal reaction conditions for the reduction of disulfides by treatment with DTT were 
established for each biological matrix. To this end, samples were reacted with 10, 25, 50 and 
100 mM DTT for 10, 20, 30 and 60 min at RT before addition of NEM; appropriate volumes of 
a 100 mM NEM stock solution in ammonium phosphate buffer were then added to neutralize 
all SH equivalents of DTT and yield an additional 10 mM excess of NEM to ensure full 
capture of additionally released thiols. An alternative incubation sequence was tested in 
which DTT was added to NEM-treated human plasma to achieve (following neutralization of 
the excess NEM) a similar final DTT concentration. Results obtained with either sequence 
were virtually identical.   
To test for the presence of acid-labile sulfide in blood cells, urine and saliva, 50 µl of NEM-
stabilized sample was placed in a septum-sealed screw-cap vial and 200 µl 0.1N HCl was 
added through the septum using a gas-tight syringe. After 10 min of incubation at RT the pH 
was neutralized by addition of 20 µl 1N NaOH, followed by vortexing and addition of 20 µL 
100 mM NEM through the septum. Internal standards were added after a further 10 min of 
incubation, and samples were then subjected to ultrafiltration followed by LC-MS/MS analysis 
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as described above. It is important to note that acid treatment will liberate sulfide from both 
LMW and protein-bound sulfane sulfur (and possibly other sulfur species). 
2.10 Alternative detection of free reduced/oxidized thiols by UPLC-QTOF analysis 
(accuracy and method cross-validation)  
25 µl of a solution consisting of 100 mM NEM with 20 mM EDTA in PBS (final [NEM] = 10 
mM; final [EDTA] = 2 mM) were added to 225 µl of whole blood (9:1 (v/v) dilution). Blood 
cells and plasma were separated via centrifugation of whole blood at 3000 g for 3 min at 4°C. 
Plasma was collected, and proteins were precipitated by mixing plasma 1:1 (v/v) with 150 µL 
of an ice-cold solution containing 5 % SSA and 10 mM NEM in Mili-Q water. Additionally, 15 
µL of the internal standard (either 2 mM glutathione ethyl ester in Milli-Q water or the same 
dual-labelled stable isotope GSH and GSSG standard mix as indicated above) solution was 
added (1:10 relative to plasma volume). The sample was mixed by vortexing, sonicated for 
20 s and centrifuged at 10000 x g for 10 min at 4°C. The supernatant was collected and the 
pellet extracted once more with the same volume of ice-cold 5 % SSA containing NEM (10 
mM) solution as before. After centrifugation at 10000 x g for 10 min at 4°C, supernatants 
were combined and measured with UPLC-quadrupole time of flight (QToF) mass 
spectrometry using an injection volume of 10 µL. 
UPLC-QToF analysis was performed on an Agilent 1290 Infinity UPLC System with a binary 
pump and autosampler coupled to an Agilent 6550 iFunnel QToF system. For analyte 
separation a Zorbax Eclipse Plus C18 RRHD 2.1x50 mm 1.8 micron column from Agilent 
was used. Mobile phase A was 0.1 % formic acid in Milli-Q water, and mobile phase B was 
acetonitrile. Separation was accomplished using the following conditions: 0-2 min: 99 % A; 2-
7 min: 99 - 1 % linear gradient. An isocratic flow at 1 % A was then run for 5 min (7-12 min) 
to wash the column. After 12 minutes in total, the proportion of A was increased again to 99 
% and kept constant for 4 min. The method takes a total of 16 min at a flow rate of 0.6 
mL/min. Temperature was held constant at 20°C. Analytes were ionized in positive mode 
(ESI) using the following conditions: gas temperature 220°C, drying gas 12 L/min, nebulizer: 
35 psig, sheath gas temperature: 330°C, sheath gas flow: 11 L/min, capillary voltage: 2.5 kV, 
nozzle voltage: 1 kV and fragmentor voltage: 30 V. Analytes were determined using 
extracted ion chromatograms of the total ion count. 
2.11  Statistical analysis  
Analyte levels were typically assessed in technical duplicates or triplicates for at least two 
independent biological samples, as indicated in figure legends. Data were analyzed with 
GraphPad Prism 7.0c for Mac. Outlier were identified by applying the ROUT method [40]. 
Data were tested for normal distribution by using Shapiro-Wilk normality testing. Data are 
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reported as mean ± SD (for technical replicates) or SEM (for biological replicates), as 
indicated in the figure and table legends. Group differences were tested either using 1-way or 
2-way ANOVA as required by experimental setting, followed by an an appropriate multiple 
comparison post-hoc test (Dunnet’s) or t-test.when just two groups were being compared, as 
indicated in the figure legend. Significance was assumed when p < 0.05. 
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3 Results  
3.1 Development of suitable detection and separation conditions 
Method development started by selecting key compounds of interest according to the 
scheme summarized in Fig. 1A, including HCys, homocystine (HCysSS), Cys, cystine 
(CysSS), GSH, GSSG, cysteinylglycine (CysGly), glutamylcysteine (GluCys), and sulfide 
This was followed by establishing appropriate conditions for the detection of these analytes 
by LC-MS/MS. To this end, authentic standards of reduced thiols were reacted with excess 
NEM in buffered solution at pH 7.4 and mixed with disulfide standards to find suitable 
separation conditions by UPLC (see reaction scheme fo reduced thiols and sulfide with NEM 
depicted in Fig. 1B). During the initial phase of development a standard C18 reversed phase 
column with a simple gradient elution profile was used for analyte separation, allowing us to 
make a number of general observations regarding their elution profile. We found that 
symmetric and mixed disulfides (which do not react with NEM as they lack a free thiol group) 
show limited retention on reversed phase material, clustering together close to the solvent 
front; this was followed by the group of maleimide-adducts of aminothiols, with S-(NEM)2 
eluting last. Thus, derivatizing reduced thiols with NEM clearly prolongs their retention time 
on the column, particularly when derivatization involves two maleimide groups, as with 
sulfide. For some compounds more than others double peaks were observed, a 
phenomenon previously described for cysteine and glutathione [41, 42]. This has been 
attributed to the formation of two diasteromeres that differ in position of the sulfur atom in 
relation to the maleimide nitrogen, depending on where the reduced thiol adds to the double 
bond of the pyrrole ring. Modifying elution conditions afforded reasonably good separation of 
NEM-containing adducts, but remained problematic for disulfides. We therefore opted for a 
multimodal resin in order to improve retention of the highly polar analytes. The mixed mode 
Aqua UHPLC column was found to offer suitable properties, combining polar separation 
characteristics with the stability and non-polar separation of a traditional C18 column. This 
allowed for better separation of the more polar thiols such as GSSG and HCysSS; however, 
cystine was still not retained well by the column and eluted with a poor peak shape close to 
the solvent front. The order of elution of other derivatives remained largely the same (Fig. 
1C). Therefore, further optimization experiments were carried out on the Aqua UHPLC 
column according to the separation procedure described in section 2.3 of the Materials and 
Methods section. Table 1 lists the structures of analytes of interest along with the specific 
cone/collision energies used for their detection and typical retention times observed using 
these separation conditions. 
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3.2 Internal standards 
Since glutathione is a major intracellular antioxidant and the GSH/GSSG ratio in plasma and 
tissues widely regarded as the ‘gold standard’ for the assessment of systemic or cellular 
redox status, we chose stable-isotope labelled GSH and GSSG to account for variations in 
ionization efficiency and possible loss of analyte during sample preparation. Consistent with 
the known dynamics of glutathione in blood [9] on spiking fresh or previously frozen plasma 
we observed a rapid loss of internal standard, unless plasma was treated with NEM before 
addition. Since this was observed with both reduced (fast) and oxidized (slower) internal 
standard we opted to alkylate the stable-isotope labelled GSH standard and only added 
internal standards to the biological sample pre-incubated with NEM for at least 10 min. This 
measure effectively prevented any loss of internal standard even after sample 
deproteinization (see section 3.8 below). The disappearance of both reduced and oxidized 
thiols was also observed on spiking blood plasma with cysteine and homocysteine.  
Considering the unique chemistry of sulfide and its reaction with two instead of one 
molecule(s) of NEM (Fig. 1B), we opted to include an additional stable-isotope labelled 
internal standard for this analyte. Preliminary studies with 34S-(NEM)2 showed that the 
degree of ionization quenching of the sulfide adduct in a variety of biological matrices indeed 
differed from that of the dual-labelled GSH adduct on occasion, justifying a separate internal 
standard for sulfide. However, those earlier experiments also revealed that this particular 
compound was not ideal as an internal standard; besides only differing by two m/z units (34S 
versus 32S) the natural abundance of the 34S isotope (4.2%) means that high concentrations 
of endogenous sulfide can lead to interference, necessitating the introduction of cumbersome 
mathematical correction factors. This problem was overcome by the use of the 
pentadeuterated NEM analogue, N-ethyl-d5-maleimide (d5-NEM) in preparing the internal 
standard, which coelutes with the regular NEM adduct of sulfide without showing any overlap 
due to the large difference of 10 m/z units.  
Therefore, a defined mixture of 13C4
15N2-GSSG, 
13C2
15N-GS-NEM and 32S-(d5-NEM)2 was 
prepared in ammonium phosphate buffer pH 7.4 and added to the mixture of internal 
standards of all analytes reacted with NEM, and compounds were detected using the specific 
MRM conditions previously established by direct infusion of individual compounds as listed in 
Table 1. The ratio between the signal intensity of each analyte and its corresponding internal 
standard was used for quantification in the biological matrix (Fig. 1D).  
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3.3 Linearity, precision, limits of detection and reproducibility of the method 
A standard calibration set was prepared to determine linearity, precision, limits of detection 
(LOD), applicability and reproducibility of the method, whilst also allowing quantification of 
the analytes in different biological matrices.  
Linearity. Accurately weighed amounts of analytical-grade reduced thiols were dissolved in 
the appropriate volume of NEM-supplemented ammonium phosphate buffer and allowed to 
react for 5 min at a 10-fold molar excess of NEM over thiol. Accurately weighed sulfide was 
first dissolved in water before addition of a defined volume of this concentrated stock to 
NEM-containing buffer in a septum-sealed reaction vial under otherwise identical reaction 
conditions. NEM-derivatized thiol and sulfide solutions were then combined with roughly 
equimolar concentrations of the oxidized thiols to yield a stock solution of all analytes to be 
tested. This mixed standard was serially diluted with buffer to yield targeted final 
concentrations of 10 M, 5 M, 1 M, 500 nM, 100 nM, 50 nM, 10 nM and 5 nM when added 
to the biological sample (2x more concentrated in the mixed standard). For most compounds 
this is well within the physiological range, except for cellular/tissue GSH levels (being in the 
low mM range), which may therefore necessitate appropriate dilution of samples before 
analysis. To each dilution of the standard calibration set and the biological samples the same 
volume of internal standard was added yielding final concentrations of 100 nM GSH, 200 nM 
GSSG, and 100 nM sulfide. This allowed adjustment of peak areas by taking into account the 
ratios between analyte and internal standard. All analytes showed excellent linearity over a 
wide range of concentrations (>3 orders of magnitude), with overall r2 values of between 
0.994 and 0.999 (Fig. 1F).  
Sensitivity and LOD. Using an injection volume of 5 µl achieved sensitivity limits were all in 
the nanomolar range, differing by class of compound and structure, with a general order of 
disulfide>thiol adduct with one NEM>sulfide (two NEM/thiol). Limits of detection and 
quantification, defined as signal-to-noise ratio of >3 and >10, are listed in Table 1. Assay 
precision will be determined at a later stage of method development. 
Applicability and reproducibility. All analytes of interest could be readily detected in fresh 
human plasma and quantified without problems in each sample measured. Between-run 
reproducibility was tested for a pooled plasma sample over several days and was better than 
20% overall.  Fig. 1 shows a typical chromatogram of standards (panel C) and a 
representative plasma sample (panel E).  
Our next efforts focussed on exploring what effects variations in reaction conditions such as 
pH and sample preparation (blood collection, cell separation, and stabilisation) may have on 
analyte concentrations detected.  
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3.4 Optimisation of reaction conditions for thiol derivatization with NEM 
Reaction conditions were optimized to perform well under biologically relevant conditions. At 
neutral pH, NEM rapidly reacts with thiols [43], and this was experimentally confirmed to 
extend to physiological pH using a thiol standard mixture. Since the reaction was found to be 
complete in under 10 min no additional work was undertaken to further optimize reaction 
temperature or time as this was considered well within the timeframe required for the 
processing of biological samples, their placement into the sample compartment of the UPLC, 
and initiation of the the first chromatographic run. 
Reaction pH is known to be critical for thiol alkylation by NEM for a number of reasons (see 
Discussion for details), and pH values in the range of 6.5-7.5 have been used in most 
previous studies. Human blood plasma deviates very little from its normal physiological pH of 
7.40 under most conditions and is naturally buffered to maintain its pH. We therefore sought 
to experimentally test these assumptions by carrying out a series of experiments with select 
analytes (GSH, Cys, HCys and sulfide), varying the pH from 6 to 9 in an aqueous buffer 
system; those experiment were complemented by additional incubations of NEM with human 
plasma at the same pH values. The results of these studies are displayed in Fig. 2.  
The results reveal clear differences between the reaction of NEM with structurally distinct 
thiols. Whereas little difference was found for the calibration curves for sulfide between pH 6 
and 9, small differences were observed for GSH; these differences became increasingly 
prominent with HCys and Cys. With Cys, a 10-fold difference in product yield was observed 
between pH 7.4 and pH 9. When fresh human plasma was added to NEM dissolved in buffer 
of different pH, the changes in peak areas were not as dramatic as with the mixture of 
reduced thiols in aqueous solution. Yet, a few notable differences were observed: peak areas 
decreased slightly with increased alkalinization for GSH and Cys and rather more markedly 
for sulfide; a small increase compare to physiological pH was also observed with Cys and 
sulfide.  
Taken together, this data suggests that adjustment of the reaction pH from 7.4 to either more 
acidic or more alkaline conditions affects product yield and/or stability of the reaction product 
to a diferent extent with different thiols, with the most dramatic variation observed with 
cysteine. If the calibration curves of the authentic standards at the respective pH would be 
used this would result in an overestimation by a factor of 10 in the case of cysteine. For 
sulfide, the same changes in pH appear to result in increased sulfide amounts to become 
available for reaction with NEM; whether this was a result of decomposition of metastable 
per/polysulfides or due to enhanced release of sulfide from non-covalent binding sites 
remains unclear at this stage. All further experiments were therefore carried out using NEM-
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containing stock solutions kept at pH 7.4. Since the physiological pH of plasma, saliva and 
cellular samples is almost always near this pH there is in fact no need to add a stabilizing 
buffer for these compartments; however, the pH of urine may vary from slightly acidic to 
alkaline, depending on nutritional habits and metabolic status; thus, checking pH after 
addition of NEM-containing buffer would seem to be advisable. 
3.5  Versatility for assesement of other thiols and sulfur metabolites 
Having demonstrated that in principle our platform technology is robust and allows sensitive, 
specific and simultaneous measurement of multiple thiols, disulfides and sulfide in plasma 
our next efforts focussed on demonstrating its versatility. To this end, we tested how 
cumbersome it would be to include an additional analyte into the existing method. Herein we 
show examples for three very different compounds: methanethiol (methyl mercaptan, 
CH3SH), N-acetylcysteine (NAC), and coenzyme A (CoA).  Establishing specific MRMs, 
optimizing cone/collision energies and subsequently testing where the compound elutes on 
the column takes approximately one day per analyte using UPLC-MS/MS. NAC and CoA did 
not differ much from other thiols in terms of fragmentation properties. Methanethiol was 
found to be extremely sensitive to in-source fragmentation, requiring a very low cone voltage 
for detection; it was also very well retained on the column, eluting between the other thiols 
and sulfide (see Fig. 1C). NAC fell within the same time window where other aminothiols 
elute, whereas CoA showed an unusually strong interaction with the mixed mode column. 
This resulted in extreme peak tailing, preventing inclusion of CoA in the current method. 
Ongoing efforts focus on developing a short method for discrete measurement of this 
particular analyte using a C18 column. Thus, in principle, many new analytes can be 
incorporated into the method within one day, although some compounds (here exemplified 
by CoA) may require additional development effort and/or alternative chromatography/elution 
conditions. 
3.6 Optimization of sample preparation procedures for plasma: protein removal and 
anticoagulant 
To allow this method to be used in translational studies [44], we focussed on the optimization 
of analysis of thiols and sulfide primarly in biological matrices. Since blood is in contact with 
all tissues, it is likely to represent not only a convenient biomarker matrix but also to play a 
central role in sytemic thiol and sulfide metabolism. A further advantage is that blood is 
relatively easily accessible. Therefore, in the present study we focused on optimizing sample 
preparation for blood (although these procedures can be easily adapted to tissues and cells).  
To avoid changes in thiol speciation (in particular sulfide) while minimizing interference with 
chromatographic separation and analyte detection, we opted to remove proteins by simple 
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ultrafiltration over a 10kDa membrane. The advantages of this approach to sample clean-up 
over protein precipitation methods include the avoidance of analyte dilution, pH changes and 
addition of organic solvents, which may interfere with the separation (please see Discussion 
for further comments).  
The choice of anticoagulant used to collect blood may have a significant impact on the 
concentrations of thiols/disulfides and sulfide measured, and previous work on glutathione 
emphasized the importance of metal chelators to minimize artificial oxidation [45]. Our first 
efforts to identify optimal conditions for combined thiol/sulfide analysis in whole blood 
therefore focussed on the choice of anticoagulant (Fig. 2A). For reasons of practicality we 
limited our comparison to using commercial vacutainer tubes. In all cases, NEM was added 
immediately after filling and before centrifugation at 800 x g for 10 min (the standard protocol 
used in many of our earlier studies). A final sample concentration of 10 mM NEM was 
chosen in all the pilot work. This had been successfully used by our group and others in the 
context of NO related research to prevent changes in concentrations of nitrite, nitrate and 
nitroso species in blood and tissues [46].   
Blood was collected from three different individuals into EDTA, heparin, citrate or serum 
vacutainers and tested in direct comparison (Fig. 2A). Citrated samples had a greatly 
reduced sulfide concentration compared to other anticoagulants, likely due to the acidic 
nature of this anticoagulant perhaps favoring volatilization of sulfide. Blood collected in 
heparin tubes showed slightly higher levels of GSH and sulfide compared to EDTA, but lower 
levels of cysteine and CysGly. Serum tubes were unsatisfactory for measurement of 
physiological levels of thiols and sulfide as they showed greatly reduced concentrations of 
the majority of thiols measured (except GluCys) and sulfide. Whether this was due to 
excessive protein thiolation as a result of the coagulation process remains speculative at this 
jucture and was not further investigated. In any case, these results seem clearly to rule out 
serum or citrate tubes for thiol redox measurements. Since the concentrations of most 
analytes measured were rather similar using either EDTA or heparin anticoagulated blood 
(Fig. 2A), and the former may have an advantage inasmuch as it minimizes thiol oxidation by 
metal chelation (obviating the need to add another chelating agent) all further validation 
experiments were carried out using EDTA as anticoagulant.   
3.7 Sample stabilisation with NEM 
All thiols are susceptible to oxidation when exposed to ambient air, and sulfide is in addition 
volatile; it would thus seem advisable to add alkylating agents such as NEM as soon as 
possible to a biological sample in order to avoid artificial shifts in the ratio of reduced to 
oxidized thiols. For blood, we reasoned that it would be advantageous to add NEM 
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immediately after collection. As expected, delaying the addition of NEM to whole blood 
resulted in lower levels of GSH being detected in plasma (Fig. 2B). In contrast, sulfide 
showed an apparent increase in concentration the longer the blood was left without 
derivatization.  Irrespective of specfic mechanisms involved it would seem advisable to add 
the alkylating agent as soon as feasible to the biological sample of interest. 
Our next efforts revolved around finding the optimal concentration of NEM to achieve 
complete alkylation (Fig. 3C). The most abundant thiol in human plasma is the single free 
sulfhydryl group of Cys-34 of serum albumin [47], which is not analysed in this method but 
will still react with (and thus consume) NEM. It has a plasma concentration in the order of 
0.3-0.4 mM in healthy human individuals; to some extent, NEM can also react with amine 
residues consuming additional equivalents. Thus, to ensure that all of the low-molecular 
weight thiols and sulfide are fully derivatized a range of NEM concentrations (1-20 mM final 
concentrations) were tested. There was no significant change in concentration between 1 
mM and 5 mM NEM for the majority of analytes. However, the concentration of NEM used for 
derivatisation of whole blood had a dramatic effect on the apparent plasma levels of GSH 
and sulfide recorded (Fig. 3C). Higher NEM concentrations significantly increased the levels 
of GSH and sulfide measured, while those of other thiols were either not affected or their 
concentrations were slightly reduced. Sulfide levels showed the largest variation with 
different NEM concentrations, tripling between 1 mM and 10 mM NEM and plateauing 
between 10 mM and 20 mM (Fig. 3C).  
A striking observation was that, at the two highest concentrations of NEM tested (10 and 20 
mM), measured plasma GSH concentration was considerably higher than the range typically 
reported in the literature [45]. By contrast, GSH and sulfide concentrations increased to a 
much lesser extent when NEM was added to plasma after its separation from RBCs (and 
other blood cells) by centrifugation (compare Fig. 3E and Fig. 3C). This data suggests that 
the observed elevated plasma concentrations of these two analytes, when higher NEM 
concentrations were added to whole blood, were an artefact resulting from leakage and/or 
transport of material from blood cells. This phenomenon was not specific to this particular 
thiol alkylating agent since even higher levels of sulfide were found when mBB instead of 
NEM was used as thiol alkylating agent and added to whole blood under otherwise identical 
conditions. A direct comparison of mBB, NEM and IAM  (Fig. 3D) revealed that the latter 
resulted in the lowest sulfide levels detected, demonstrating that the nature of the alkylating 
agent applied can have a marked influence on the levels of sulfide detected. 
As centrifugation time itself contributes to the delay between collection of blood and 
prevention of thiol oxidation by addition of NEM and consequent loss of GSH (as observed in 
Fig. 3B) and other thiols the centrifugation protocol was also optimized for centrifugation 
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speed (800-3000 x g), centrifugation time (1-10 min) and hemolysis of RBCs (Fig. 4A,B). 
The latter is of critical importance due to the very high concentration of GSH and sulfide 
within RBCs, such that small numbers of ruptured cells can lead to dramatic increases in the 
apparent plasma concentration of these analytes. None of the centrifugation protocols tested 
induced hemolysis of RBCs as assesed by UV-vis spectrophotometry of the plasma obtained 
after centrifugation, a simple procedure that can detect concentrations of free hemoglobin as 
low as 10 nM (a low-grade hemolysis corresponds to absorbance values of > 0.2 [39]). 
Nevertheless, a consistent finding was that the longer/low-speed centrifugation (800 x g, 10 
min) resulted in considerable leakage of GSH from the cells (Fig. 4A – GSH, compare pink 
vs. blue bar).    
Therefore, the optimal protocol chosen to preserve the natural speciation of thiols and sulfide 
in blood was to add NEM to a final concentration of 10 mM as quickly as possible upon 
collection of blood, combined with a short/rapid centrifugation procedure (1 min at 3000 x g).  
3.8 Sample storage and stability 
For the most part, samples will have to be collected over longer periods of time (and in case 
of multicenter studies even at different locations) requiring storage in the frozen state before 
analysis. We therefore felt it was important to ensure that signal intensities of key analytes 
did not suffer a dramatic loss upon freeze/thaw. As shown in Fig. 4C, instead of any 
significant descrease, some concentrations notably increased after freeze/thawing, 
especially CysGly whereas others such as sulfide did not change at all. The only exception 
was NAC, which dropped by 30-50% after a single freeze/thaw compared to immediate 
analysis. However, another obvious finding from these studies was that the extent of 
concentration changes observed varied dramatically from individual to individual and 
between analytes, ranging from a few percent to >3-fold. Further stability tests with NEM-
treated samples showed no significant changes in the levels of the analytes when kept for 
extended time in the refrigerated autosampler compartment or subjected to an additional 
freeze/thaw (Fig. 3D). Therefore, human plasma samples stabilized with NEM can be frozen 
without apparent loss in concentration of analytes; however, absolute concentrations 
measured differ from those apparent on immediate sample analysis. 
3.9 Accuracy for measurement of glutathione redox status and comparison of 
analytical results 
We sought to demonstrate the accuracy of our platform technique by comparing the results 
obtained by an independent laboratory. Instead of ultrafiltration, this laboratory used a protein 
removal technique accepted and optimized for GSH/GSSG mesurements, i.e. by precipitaion 
sulfosalicylic acid (SSA), along with a different chromatography (regular C18 instead of mixed 
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mode material) and mass spectrometry principle (ToF high resolution instead of triple 
quadrupole; see Methods for details). Two other thiols (Cys, HCys) and one disulfide 
(HCysSS) were also included in the comparison in addition to GSH/GSSG. The 
concentration of these analytes was compared between both methods in plasma from 10 
healthy human volunteers (Fig. 5). On comparison of Method A (ultrafiltration and triple 
quadrupole) with Method B (SSA deproteinisation and QToF) we found that deproteinization 
of samples with SSA leads to a statistically significant understimation of GSH and GSSG, 
while Cys, HCys, HCySS yielded consistently higher concentrations (Fig. 5A). These 
differences are evident on Blant-Altman comparison of the methods (Fig. 5B). When 
ultrafiltration was used instead of SSA deproteinization, both methods yielded comparable 
results (Table 3). Sulfide levels were only marginally affected from those using ultrafiltration 
(Table 3). 
3.10 Assesment of total and bound thiols by treatment with DTT 
Total amounts of a specific thiol in a biological sample can be determined by reduction of all 
disulfides by DTT before NEM addition and analysis, while the corresponding free thiol is 
assesed in DTT untreated samples. The bound thiol is obtained by calculating the difference 
of total thiols-free thiols. First, to ensure complete reduction of all disulfides (including sulfide) 
we determined the minimally effective concentration of DTT and the incubation time required 
to achieve the highest final concentration of LMW thiols and sulfide in the reaction solution. 
Complete reduction was achieved by treatment of plasma with 50 mM DTT for 10 min at RT 
(sample workflow is shown in Fig. 6A). Similar results were obtained by analyzing other 
biofluids, including saliva and urine, whereas human blood cells required 100 mM DTT and 
30 min incubation for complete reduction (see below).  
There were no significant differences in the final concentration of thiols in plasma samples 
reacted with NEM before reduction compared with samples reduced with excess DTT and 
then reacted with NEM.  
As a proof-of-concept study, we determined the steady-state concentrations of free reduced 
and oxidized thiols as well as the total thiol content in plasma of 10 healthy human volunteers 
(Table 2). The difference between total thiol concentrations and the sum of free 
reduced/oxidized thiols corresponds to the amount of bound thiols [20]. The concentrations 
listed correspond broadly to values previously reported in the literature [48]. However, the 
distribution of circulating concentrations among healthy human volunteers highlights a 
number of aspects that are usually less obvious by looking at averages. First, there are 
considerable differences in concentration of free thiols between individuals, varying from 2-3 
fold in some cases to as much as 10-fold for other analytes. Second, the ratios of reduced 
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over oxidized thiols varies markedly between glutathione, cysteine and homocysteine. Third, 
amounts of bound thiols are generally higher than circulating concentrations of free reduced 
thiols; this is particularly striking for GluCys and sulfide for example, where bound sulfide 
exceeds free sulfide by a factor of 100. Persulfide and methanethiol were not detected in any 
plasma sample. However, solutions of NEM-derivatized standards of persulfide (formally, the 
disulfide of H2S in its anionic form) were found not to be stable over time, representing a 
methodological limitation that is not easily overcome without switching to another alkylating 
agent.  
Overall, these data show that our method can also be applied for high-throughput 
determination of free and protein bound thiols in human plasma.  
3.11 Acid-labile sulfur and redox measurements in blood cells and other biofluids 
In addition to the possibility of measuring free thiols and subject aliquots of the same 
biological specimen to additional reduction with excess DTT (before or even after addition of 
NEM) to liberate bound thiols, another sample aliquot can be pretreated with acid, 
neutralized and then reacted with NEM to measure acid-labile sulfur (and other thiol-
containing species that may be released upon this treatment; see Fig. 6A for workflow). Fig. 
6B-D shows exemplary results using this sample workflow for blood cells and two other 
biofluids, urine and saliva. It is immediately apparent from this comparison that not only 
absolute concentrations differ dramatically between different biospecimen, but also the 
distribution of thiols (i.e. the proportion of free versus bound, and acid-labile). Similar to 
plasma (Tab. 2), bound cysteine exceeded free levels by more than an order of magnitude in 
urine and saliva; however, bound glutathione was only found in saliva, not urine or blood 
cells. Somewhat lower levels of cysteinylation but essentially no glutathionylation were found 
in blood cells. Significant amounts of acid-labile sulfur are present in saliva, urine and blood 
cells. Unexpectedly, not only sulfide concentrations were increased following sample 
acidification, but some thiols also showed clearly higher levels compared to untreated 
controls. This was particularly evident for methanethiol, concentrations of which increased 
approximately 50-fold upon acidificaction in urine; methanethiol concentrations in blood cells 
and saliva remained below the quantifiable limit. It is important to point out that under acidic 
conditions the NEM-sulfide adduct is likely to originate not only from reaction with free HS- 
but also with both protein-bound and LMW polysulfides due to the susceptibility of these 
compounds to acid hydrolysis. 
In summary, an additional straightforward sample pre-treatment allows further expansion of 
the measurement opportunities to include acid-labile sulfur species in biological samples. 
While there seems to be some overlap between DTT-reducible and acid-labile material 
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distinct differences remain, suggesting different chemical characteristics of the biological 
material susceptible to reduction and acid-treatment. 
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4 Discussion  
We here outline a novel specific, highly sensitive and robust mass spectrometry-based 
approach for the measurement of the thiol redox metabolome capable of quantifying total 
and free thiols, and their corresponding disulfides as well and sulfide in complex biological 
matrices such as blood, saliva and urine. Specifically, we describe our validation work 
focusing on i) the development of the analytical procedure, i.e. suitable detection and 
separation conditions, quantification strategy (external and internal standards, linearity, and 
versatility of the method); ii) optimization of sample preparation, using blood as starting 
material (choice on anticoagulant, sample stabilization, centrifugation and storage); iii) 
versatility of the method with examples of how further compounds of interest can be included 
for a more comprehensive coverage of the thiol redox metabolome in the future;  iv) 
determination of the accuracy for detection of glutathione redox status as compared to an 
optimised, well established method; v) analysis of the thiol metabolome (including total and 
free thiols and their corresponding disulfides, as well as hydrogen sulfide) in plasma samples 
of 10 healthy human volunteers, as well as in blood cells, urine and saliva. Taken together, 
this data indicates that the approach can be used to characterize the redox metabolome in 
patient cohorts and animal models of disease. It can therefore be applied in clinical and 
translational studies in search for novel prognostic and diagnostic strategies for patient 
stratification; moreover, it may assist in identifying novel interventional approaches for the 
treatment of redox diseases [3]. 
4.1 Is there a need for yet another method to determine thiol redox status? 
There is no shortage of analytical methods for the determination of biological thiols (for 
recent reviews see [49, 50]), and many more assays appeared just in the last couple of 
years. Several of those more recent additions to our analytical armamentarium use a 
combination of some form of chromatographic separation (HPLC, UPLC or capillary 
electrophoresis) and mass-spectrometry for detection. In most (albeit not all) cases, the latter 
offers better selectivity and higher sensitivity compared to earlier spectrophotometric, 
fluorimetric, chemiluminescence or electrochemical detection approaches. While there are 
plenty of choices for the quantification of reduced thiols, much fewer techniques exist for the 
measurement of oxidized thiols, in particular at their low natural abundance; however, this is 
of utmost importance for an accurate assessment of thiol redox equilibria. Given the 
significance of glutathione as cellular antioxidant the majority of analytical developments 
revolved around GSH/GSSG. Since the pioneering analytical work of Reed et al [15]  most 
investigators are aware of the need to prevent thiol oxidation in order to avoid an artificial 
elevation of disulfide levels. . However, not only GSH/GSSG but also the extracellular 
cysteine/cystine ratio is an important read-out of the whole body redox poise (and apparently 
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uncoupled from the glutathione redox) [51], and the ratio of cystine and glutathione has 
recently been proposed as a new biomarker for oxidative stress in the cardiovascular 
disease setting [52]. Yet, an even simpler measurement of total serum free thiols by mean of 
Ellman’s reagent has been shown to predict mortality in patient cohorts [23, 24]. How the 
latter relates to glutathione and cysteine redox state is currently unknown. While the 
complexity of changes in extracellular thiol levels has been recognised and the dynamic 
interaction between free reduced and oxidized as well as protein-bound thiols been defined 
as “plasma redox thiol status” more than two decades ago [53] the main factors and 
regulatory element that define these interactions in whole blood remain ill defined. This 
uncertainty is accompanied by new developments that appear to highlight the involvement of 
sulfide and associated metabolites such as inorganic and organic persulfides and 
polysulfides [5, 6, 26]. This interaction gives rise to oxidized thiols in which the sulfur of the 
SH group of cysteine, glutathione or sulfide (and likely other thiols) is bound to one or more 
sulfur atoms; the properties of the resulting thiol derivatives differ fundamentally, both 
chemically and biologically, from the originating thiols [54, 55].  
Moreover, even seemingly well characterized compounds such as glutathione seem to have 
additional actions beyond those of their classical antioxidant function, which would seem to 
warrant further exploration [56]. Yet, many pitfalls surrounding its analysis in cells and 
biofluids (some of which are known for decades) often appear to have been neglected and 
remain to be better characterized to avoid the enormous variations in GSH/GSSH ratios 
reported in the literature [57]. Even sophisticated, validated and robust methods for the 
simultaneous determination of glutathione and cysteine redox state [58] would seem to leave 
room for improvement inasmuch as pre-analytical sample handling is somewhat 
cumbersome and time-consuming, involving mutltiple steps, and total assay time is rather 
long by today’s standards. More importantly, however, the technique used in this particular 
case (which is based on the technique established by Reed et al [15]) is unsuitable for the 
analysis of thiols that do not also contain an amino group such as sulfide or methanethiol. 
Hence, novel analytical methods with improved sensitivity and specificity, a simplified 
workflow and higher speed of analysis without compromising robustness and versatility are 
required to allow future study of the complex interactions between different elements of the 
thiol redox metabolome in larger numbers. Herein, we provide one example for how such an 
approach might be put into action.  
4.2 Establishing an analytical platform for detection of the redox metabolome 
Here we describe the necessary steps needed to establish an analytical platform for high-
throughput characterisation of the thiol metabolome in biological matrices. As soon as the 
analytical instrumentation is available, the first fundamental step to this end is to define the 
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relevant target analytes as well as the internal standards for their quantification; from there 
on, one can proceed with optimization of detection and separation conditions as well as an a 
critical assessment of linearity, precision, LOD and reproducibility of the method. These 
steps are clearly dependent on the type of instrumentation available, but in part also on the 
different chemistry of the analytes intended to be covered. However, the main objective of 
the present method development was not to identify ideal conditions for analysis, but rather 
to find conditions that are fit-for-purpose for high-throughput redox profiling of large numbers 
of samples under everyday conditions. To this end, we found that not the instrumentation 
available but rather the sample preparation is the most important factor that defines the 
qualitative and quantitative results.  
We chose human blood as suitable starting material for our development. The reason for this 
choice was severalfold: not only is it a readily accessible and relatively abundant starting 
material, but it also represents a sort of systemic equilibration medium that is in contact with 
all other compartments of the body [3]. The redox buffering capacity of the blood (and in 
particular of RBCs) is notoriously high, and it appears to be kept constant by multiple 
enzymatic and non-enzymatic mechanisms [3, 59]. For the same reasons the determination 
of ‘redox reserve’ (total thiols) and ‘redox status’ (ratio of reduced/oxidized thiols) in blood 
may be relevant to understand the status of biological fitness and resilience of an individual 
(or animal) under study.  
The first critical steps during development were therefore to find a way to stabilize the 
sample, to separate cellular components from the plasma without damaging RBCs (which 
contain millimolar concentrations of glutathione [59]), in a quick and straightforward way, 
compatible with rapid and reproducible collection of clinical specimens in a critical care 
setting, for example. We found that one of the easiest ways to collect blood in this context 
was to choose commercial EDTA vacutainers since this anticoagulant is also a metal 
chelator, which may help avoiding secondary metal-dependent oxidative reactions (like the 
Fenton reaction). Reduced thiols in EDTA anticoagulated blood can then be stabilized by 
treatment with an excess of alkylating agent, added within the first 1-2 minutes after blood 
withdrawal. In the present study we used NEM for this purpose, whilst others have used 
different alkylating agents such as IAM or mBB. We opted for NEM due to its superior speed 
of reaction with SH groups at physiologic pH (see below). Regardless of the nature of 
alklyating agent employed in this context, we observed that addition of these chemicals to 
whole blood lead to an artifactual increase in GSH and sulfide concentrations in plasma if 
centrifugation is carried out at low speed for too long. This problem was circumvented by use 
of a high-speed/short-centrifugation protocol for cell separation, indicating that this 
phenomenon was an artefact possibly due to an aklylation-induced increase in RBC 
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membrane permeability. Indeed, NEM is well known to affect RBC membrane properties, 
inducing a loss of membrane asymmetry and exposure of phophatidylserine as well as to 
modifying critical thiols in ion channels and transporters, thereby affecting ion exchange 
processes, decreasing cell deformability and increasing membrane leakage [59]. 
Another important factor that requires careful consideration in methodological developments 
is the choice of protein removal method. Biological fluids such as plasma are complex 
matrices, the constituents of which can potentially cause interference with chromatographic 
separation and analyte detection by e.g. lowering ionization efficiency or ion suppression. In 
the present study, biological samples were cleared before analysis, and the majority of 
proteins were removed by ultrafiltration over a 10kDa cut-off membrane using centrifugal 
columns. The classical methods described for determination of aminothiols, specifically GSH, 
using either chromatographic techniques or enzymatic assay, also normally include a protein 
removal step. Many standard deproteinization procedures are based on addition of acids 
(trichloroacetic acid, sulfosalicylic acid) or metals like zinc sulfate/NaOH. Clearly, either of 
these methods would cause drastic changes in pH, which may affect detection of sulfur 
species and sulfide [27]. In fact, sulfur species are well known to be particularly labile under 
acidic conditions; on the other hand, sulfur can be released from thiols under alkaline 
conditions [27], leading to an artificial elevation of sulfide. In addition, zinc sulfate is known to 
trap free sulfide and form a water-insoluble ZnS precipitate. Alternative protein removal 
processes include addition of polar organic solvents such as methanol, acetonitrile or 
acetone, or solid phase extraction. We observed that using organic solvents for protein 
precipitation decreases the recovery of GSSG; moreover, the high concentration of organic 
solvent in the sample sometimes interferes with the chromatography (which often requires an 
almost complete aqueous phase to start with). Therefore, in order to quantify aminothiols and 
sulfide using an identical sample processing procedure, clearing samples by ultrafiltration, 
which does neither change the pH nor add any acid or solvent, to us appears to be best 
practice, at least for matrices such as plasma. 
A further important step was to determine the stability of the samples after freeze/thaw. We 
found that except for NAC (levels of which dropped by 30-50% after freeze/thaw compared to 
immediate analysis) concentrations of all other thiols did not drop but rather increased in 
concentrations after freeze/thaw. The reason for this behavior is not immediately obvious, but 
clearly there is no problem with the stability of the thiol-NEM adduct. We suspect that this 
observation may be related to the stability of thiol derivatives that previously escaped 
detection (perhaps a metastable compound that decomposed during the freeze/thaw process 
such as a persulfide and/or polysulfide). However, levels of sulfide did not change under the 
same conditions, suggesting that the product of decomposition of these per/polysulfides 
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might be a higher oxidized form not captured by our assay. Interestingly these effects of 
freeze/thaw were not observed when proteins were removed by addition of SSA. This 
suggests an alternative explanation that is even more intriguing: conceivably, aminothiols 
may exist not only in free and protein-bound form (whereby binding is via a mixed disulfide 
and therefore DTT-reducible), but a fraction of them also binds to proteins in a non-covalent 
fashion. When protein conformation is changed by precipitation with acid/organic solvents or 
as a consequence of a freeze/thaw process this non-covalent association is perturbed, 
making more aminothiols available for trapping by the excess NEM present. This scenario 
might also explain the apparent differences in absolute concentration of analytes (which were 
independent of the detection method) when plasma was processed by ultrafiltration versus 
acid precipitation; moreover, it might offer an explanation for our observation that not only 
sulfide, but also the concentration of some aminothiols increases upon acid treatment. The 
notion of non-covalent protein binding of thiols is also consistent with the observed 
concentration-dependence of NEM in plasma - why should levels of certain aminothiols (and 
sulfide) otherwise further increase with higher NEM concentrations unless they are removed 
from an equilibrium? This concentration-dependent phenomenon was particularly promiment 
with sulfide (see Fig. 3E), and consistent with a recent report that H2S non-covalently binds 
to albumin and hemoglobin [36]. These aspects of the thiol redox metabolome would seem to 
warrant further investigation as it might offer yet another, hitherto unrecognized level of redox 
regulation by modulation of protein association.  
4.3 Choice of alkylating agent - Why NEM? 
Many different thiol alkylating agents and strategies have been developed over the years, 
and compounds used not only differ in chemical structure and reactivity but also in the 
mechanism by which they interact with thiols. Therefore, selection of the most appropriate 
compound for thiol derivatization will be determined by the purpose of its use [60, 61], for 
example whether the goal includes either labelling or blockage of reactive thiol groups in 
proteins, thiol quantification in biological samples, or the prevention of autoxidation.  
NEM is well known for its usefulness in characterizing sulfur metabolism due to its propensity 
to rapidly react with SH groups [62]. As a result of its reaction with protein thiols and SH-
containing cofactors it can inhibit intermediary metabolism, block vesicular transport, activate 
specific ion channels and interfere with cell replication, for example. Half a century ago, it 
was also employed for the spectrophotometric measurement of SH groups [63]. NEM and 
related maleimides have since been widely used for the analysis of thiols, including 
glutathione [64] [65], for the prevention of GSH autoxidation [66] to stabilise human blood for 
later quantification of thiols/disulfides [67]; even in a similar workflow for sulfur pathway 
analysis using a different chromatographic separation [68]. It has also been known for some 
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time to react with sulfide [38, 43]. However, to the best of our knowledge this property has 
not been used for development of a combined method for thiol and sulfide detection using 
mass spectrometry. 
Of note, the compound’s specificity for thiols is not absolute. At high concentrations, NEM 
can also react with amino groups of peptides/proteins and aminothiols [69]. In fact, its 
specificity for SH groups strongly depends on reaction conditions; the side-reaction with 
amines does not pose a major problem as long as the pH of the reaction solution is kept near 
neutral. However, reagent concentrations in excess of those found optimal for the majority of 
analytes in a specific biological matrix (determined to be 10 mM NEM for plasma in the 
present study) may lead to lower apparent concentrations of select analytes. Cys is a case in 
point and has been shown to undergo intramolecular transamidation to form a cyclic reaction 
product; this reaction can run to completion under alkaline conditions [69], and this may well 
account for the progressive descrease in apparent Cys levels in Fig. 2F (when increasing 
NEM concentrations were tested) as well as the drop in reaction yield when pH was changed 
from 7.4 to 9 (Fig. 2B). Yet, apart from these examples and in spite of its widespread use as 
a pharmacological and analytical tool for decades, it is somewhat surprising that the reaction 
mechanism of NEM with thiols has not been investigated in much more detail (this could 
change in the near future as the underlying chemistry also forms the basis for numerous 
applications in materials chemistry including the surface modification of porous polymeric 
monoliths used in chromatography columns [70, 71].  
In order to appreciate NEM’s uniqueness among thiol-reactive compounds and explain some 
of our experimental findings with different aminothiols and sulfide (as well as polysulfides) it 
may be informative to briefly review key mechanistic aspects of the chemical reaction. This is 
of importance since reaction conditions not only affect the stability of NEM and the final 
reaction product (both of which are subject to alkaline hydrolysis [43, 72, 73], but also speed 
and nature of the reaction itself as well as its specificity for SH groups over reaction with 
amines. The pH plays a central role not only for reagent and product stability, but also 
because it affects, along with the pka of the SH group, the amount of thiolate available. It is a 
fortunate coincidence for analytical chemistry that the reaction of NEM with thiols proceeds 
optimally around the physiological pH, i.e. in the range of 7 to 7.5. 
 
Scheme 1: Mechanism of the reaction between N-ethylmaleimide and thiols (RSH) in aqueous solution. R- alkyl chain 
with additional functional groups (as in aminothiols), hydrogen (as for sulfide) or sulfur chains of various length (as in 
polysulfides) 
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NEM and related maleimides are electron-deficient compounds (electrophiles) that 
participate in chemical reactions by accepting an electron pair of a nucleophilic compound 
such as a thiol. As a maleic acid derivative it also has an activated double bond with which 
thiols can react. The pH-dependence of NEM’s reaction with GSH and Cys [43, 74] indicated 
that only the thiolate (RS-) and not the undissociated thiol (RSH) reacts with NEM. The 
mechanism involves a nucleophilic addition of the thiolate (a strong nucleophile) onto the 
olefinic (C=C) bond of the maleimide ring, forming an intermediate carbon-centered anion; as 
a strong base this immediately abstracts a proton from the conjugate acid (RSH) or from 
water, yielding the thioether (see Scheme 1). Reactions of a nucleophile with an ,-
unsaturated carbonyl (or another electron-withdrawing group) are known as ‘Michael addition 
reactions’ of which the thiol-NEM reaction is a special case. Since the sulfur can add to either 
side of the double bond it gives rise to different diastereomeres (see Fig. 1B), sometimes 
complicating the chromatographic separation of thiols [41] by leading to double peaks. 
Formation of the maleimide-thiol adduct was long thought to be irreversible (unless subjected 
to electrolysis). More recent studies, however, have documented retro reactions to occur 
even under physiological conditions, explaining e.g. the faster-than-expected cleavage of 
certain anti-cancer immunoconjugates and PEGylated products in circulation [75]. For 
analytical purposes, this is not a concern as such reactions typically proceed over many 
hours/days and require elevated temperatures. 
The reaction of NEM with sulfide deserves special attention not only because two molecules 
of NEM bind to either side of the sulfide-sulfur (Fig. 1B and Tab.1), but also because the 
same reaction can occur with polysulfides (as demonstrated here for hydrogen persulfide; 
see section 3.9). The NEM adduct of S2
2- (Tab. 1) was found to be unstable and, over time, 
decompose to yield additional S-(NEM)2. The reason for the instability of this thiol adduct is 
not known, but may be related to the ease with which sulfide chains can break and/or how 
favorable e.g. the NEM-S radical is as a leaving group. Whatever the reason, the instability of 
S2(NEM)2 is in line with recent findings by Akaike’s group demonstrating that NEM is 
unsuitable for the determination of cysteinepersulfide/polysulfide concentrations in biological 
tissues (Suppl Fig. 2 in [76]). Extrapolating those results to hydropolysulfides (Sx
2- where x 
can be 2-7) one may expect that part of the sulfide detected by NEM in plasma may not 
originate from free HS- but be derived from organic and inorganic per- and polysulfides. Our 
comparson with mBB (the current “gold-standard” for sulfide measurement) suggests that 
this reagent may suffer from the same limitations. Thus, measured sulfide concentrations 
with these reagents may represent the sum of free HS- and per/polysulfides, and this 
warrants further investigation. If in addition free sulfide is also in equilibrium with protein 
associated forms it may be difficult if not impossible to determine the concentration of free 
sulfide in a given biological system – however, the sum of free and non-covalently bound 
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sulfide and polysulfide (or simply “NEM-sensitive sulfide”) may still be a biological meaningful 
measure. 
NEM has a number of advantages over other thiol alkylating compounds. This includes 
foremost the speed of reaction with thiols, which is considerably faster than that of mBB or 
IAA/IAM. This makes it ideally suited for the prevention of autoxidation of thiols to their 
disulfides during sample preparation. Another advantage is that as an uncharged molecule, it 
easily penetrates cell membranes – a property it shares with mBB and IAM. While this can 
be an advantage for the analysis of tissue and intracellular biothiols, we here show that the 
same property can also lead to an overestimation of true plasma levels unless certain 
sample handling conditions are met. An advantage that is particularly relevant for mass 
spectrometric detection is the fact that reaction with NEM improves the ionization efficiency 
of thiols [77], which explains the excellent sensitivities achieved using ESI-MS/MS, for 
example.  
4.4 Assessment of free and bound thiols in human plasma and other biofluids; 
workflow extension to include acid-labile sulfide 
Not only can thiols be oxidized (in vivo and artificially during sample handling) to form 
symmetric disulfides (e.g. from GSH, GSSG and from Cys, CysSS), they also engage in the 
formation of mixed disulfides leading to formation of both LMW and protein disulfides. It was 
proposed that these protein-bound asymmetric disulfides may either represent a post-
translational modification or be involved in inter-organ thiol transport [3]. It is important to 
note that formation of protein-bound asymmetric disulfides may mask detection of a 
particular thiol, if only free thiol concentrations are assessed. Therefore, if determination of 
the total amount of a specific thiol (like HCys) is required for diagnostic or prognostic 
purposes, total (bound+free) thiol concentrations are determined following reduction of the 
covalent bond between the protein thiols and the LMW thiol. Indeed, determination of total 
HCys was demonstrated to be more predictive of certain pathophysiologies as compared to 
free HCys [78]. For this purpose we subjected the biological samples tested (plasma, blood 
cells, urine, and saliva) to reduction by DTT. To ensure complete reduction of all bound thiols 
(incl sulfide) we determined that the minimallly effective concentration of DTT and incubation 
time required to achieve the highest maximal concentration of LMW thiols and sulfide in the 
final reaction solution was 50 mM DTT and 10 min incubation at RT for all biological matrices 
tested except blood cells. The latter matrix required 100 mM DTT and 30 min incubation for 
complete reduction, emphasizing the importance to validate each step of the analytical 
procedure for the biological matrix intended to be investigated. For plasma analysis DTT was 
added to NEM-stabilized plasma. However, no significant difference in final concentrations of 
total thiols were found between samples that had been reacted with NEM before reduction 
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and those that were reduced with excess DTT and then reacted with NEM; this demonstrates 
that, in contrast to alkalinization which leads to hydrolysis and ring-opening of the thioether 
[72], the thiol-maleimide adducts formed are stable under acidic conditions. 
Acid-labile sulfur is found in bacteria, mammalian and plant cells/tissues, and various 
analytical methods are available for its quantification [79, 80]. However, origin and biological 
role of this “pool of sulfide” remains enigmatic. While its presence in cells and tissues has 
been ascribed to metal-sulfide complexes such as iron-sulfur proteins (e.g. aconitase 
involved in intermediary metabolism) and Fe-S clusters in complexes of the mitochondrial 
respiratory chain, sources in biofluids are believed to be mainly organic or inorganic per- and 
polysulfides. Thus, the additional sulfide demonstrated here to be captured as NEM-adduct 
following sample treatment with acid may originate from a variety of sources including 
protein-bound and LMW polysulfides. Some but not all of the DTT-reducible thiols may be 
acid-labile, although these two classes have been shown earlier to be chemically distinct 
[81].  
4.5 Assesement of other thiols and sulfur metabolites: versatility, limitations and 
outlook 
Herein we show that this method may easily be adapted to measure additional very different 
compounds, including CH3SH, NAC and CoA. CH3SH is a bacterial metabolic product that 
also arises as a result of methylation of sulfide and methionine transamination in mammalian 
cells [82-84], and a human methanethiol oxidase has been identified, which metabolizes 
CH3SH to H2O2, formaldehyde and sulfide [85]. We found CH3SH to be very well retained on 
the column, eluting between the other thiols and sulfide but to be extremely sensitive to in-
source fragmentation. NAC assumes particular importance in bioavailability monitoring 
following its oral application as antioxidant or as a mucolytic drug. Determination of CoA in 
plasma and other body fluids may also assume a particular importance for redox-related 
studies, because it is a quantitatively important thiol involved in intermediary metabolism that 
engages in S-thiolation reactions in much the same manner as glutathione [86, 87]. We had 
some technical difficulties with this particular analyte as the NEM adduct of coenzyme A was 
retained too strongly by the column with multiple mechanisms of retention, making it 
impossible to measure circulating plasma concentrations of this important intermediary 
metabolite along with other thiols and sulfide in the same run. Nevertheless, we are confident 
this can be resolved using either a different separation column or modified chromatographic 
conditions, and this is a focus of our ongoing efforts. This method may be also implemented 
to assess further key intermediates of the methionine recycling and transsulfuration pathway 
by the addition of further related compounds such as methionine, S-adenosyl-methionine, S-
adenosyl-homocysteine and cystathionine to the existing method, eventually enabling to 
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capture the sulfur metabolome in its entirety.  
It is important to note that sulfide levels assessed here by NEM derivatisation are higher 
compared to methods using other protocols employing mBB [33, 35]. In our hands, absolute 
“free” sulfide levels are strictly dependent on the alkylating agent used, and may depend on 
the chemistry of the reaction of the alkylating agent; very different concentrations in apparent 
sulfide concentrations were found with aliquots of the same sample using NEM, IAM or mBB. 
The reason for these differences warrants further elucidation. Of note, other reports 
demonstrated that e.g. dBB can extract sulfur from other sources [88], and that NEM reacts 
differently with polysulfides as compared to IAM or IAA [76]. 
4.6 Strengths and limitations 
The platform technology we present here for the measurement of reduced and oxidized thiols 
in combination with sulfide related metabolites appears to be robust, sensitive and versatile. 
Its strengths include the possibility to measure the thiol redox metabolome including total and 
free thiols and their corresponding disulfides as well as sulfide in complex biological 
matrices; the technique can be easiliy combined with other compatible analytical procedures 
for detection of NO metabolites and nitrosospecies, as established by us before [46, 89], 
using NEM for stabilisation of thiols. This may provide a deeper understanding on the 
systemic thiol redox state within the RSI. We made an effort to simplify workflows for sample 
preparation and storage, realizing there will be a need to translate critical steps into easy-to-
follow standard operating procedures, in particular when measurements are to be carried out 
in large numbers, human studies are run in a multi-center fashion and/or biobanked samples 
are used. Lack of reproducibility and robustness or a very particular sample handling 
requiring specialist training could easily make a particular method wrongly appear unsuitable 
for use in clinical studies, or worse perhaps, lead clinicians towards incorrect treatment 
decisions.  
Despite careful optimization, some technical limitations remain. In the current configuration 
these relate to the relatively poor retention of cystine on the column, which together with an 
unknown and variable interference from plasma constituents causes ionization quenching, 
leading to an underestimation of the true concentration of this disulfide in plasma. This 
appears less of a problem (or no problem at all) in other biological matrices such as RBCs 
and murine tissues (Erkens, Suvorava et al., submitted manuscript) and may be partially 
overcome by using the standard addition method to determine absolute concentrations. 
Moreover, as discussed above sulfide levels appear higher than with other methods, calling 
for a systematic comparison of the leading methods described for sulfide assessement [27, 
31]. 
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Furthermore, there may be a need for additional methods to cover the per- and polysulfides 
as important compounds bridging aminothiol and sulfide chemistry. As discussed above, a 
major limitation of the application of NEM is the fact that it cannot be used for detection of 
per- and polysulfides, for which the use of β-(4-hydroxyphenyl)ethyl iodoacetamide was 
carefully optimized and successfully applied in cells and tissues by the group of Akaike and 
co-workers [76]. The inclusion of these compounds for assessment of the redox metabolome 
would seem to be a sensible complementary approach to the analytical platform we here 
introduced.  
4.7 Summary and perspective: main lessons learned from this development 
We have outlined a novel specific, highly sensitive and robust mass spectrometry-based 
approach for quantification of the thiol redox metabolome. During the development of this 
analytical approach, we realized that the majority of variability that can be appreciated in the 
literature assesing aminothiols (and even more in the literature describing the methods to 
assess sulfide) originates from sample processing procedures rather than the actual 
analytical method itself. The use of authentic standards and stable isotope labelled internal 
standards (which are readily available for most aminothiols and sulfide) allow optimization of 
these methods with limited effort. The choice of analytes to be measured and the availability 
of the standards should drive the optimization procedures. However, procedures of sample 
stabilization, for cellular separation and/or isolation (including centrifugation and eventually 
tissue digestion with detergents), conservation and freeze/thaw cycles all profoundly affect 
the results produced and therefore also require careful optimization for each biological matrix 
of interest. Although the analytical approach with NEM presented here is not suited to cover 
the per- and polysulfide interface, the principles described here may be applied to find an 
approach allowing detection of an even broader spectrum of metabolites belonging to the 
thiol redox metabolome. In conclusion, these principles can be applied to assess the thiol 
redox metabolome in patient cohorts and animal models of disease, thus allowing the 
identification of the regulatory nodes of redox signalling, while enabling diagnosis, risk 
assesment, patient stratification and prognosis of redox dieseases.  
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11  Figures and Legends 
 Figure 1 
 
Figure 1: Development and optimization of the analytical procedure for detection of 
the thiol redox metabolome. (A) Metabolic pathways defining the thiol redox metabolome. 
(B) Reaction of NEM with sulfide and aminothiols (using cysteine as an example); the two 
positions where the sulfhydryl group can add to the double bond (Michael addition reaction 
with sulfur adding either to C3 or C4 of the maleimide ring) leading to the formation of two 
distinct diastereomers are indicated (with sulfide four different diastereomers can be formed). 
(C) Chromatographic separation and selective detection by tandem mass spectrometry of 
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authentic stock solutions of all analytes using full registration for the entire run. (D) 
Chromatograms of stable isotope labelled internal standards. (E) Representative 
chromatogram of the same analytes at their natural abundance in human plasma using 
specific time windows for selected groups of compounds. (F) Linearity of detector response 
for main analytes (n=3). 
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Figure 2 
 
Figure 2. Effects of pH on the measurement of aminothiols and sulfide using NEM. The 
effect of pH was investigated in a simple aqueous buffer (A) and in plasma. (B). (A) Standard 
curves were prepared at four different pH values: 6, 7.4 (physiological), 8 and 9, using NEM 
in ammonium phosphate buffer of the appropriate pH; the inset represent the percentual 
changes of peak area/internal standard peak area as compared to the same values obtained 
at pH 7.4 (black bars) for a 1 µM standard concentration..  The largest impact of pH is seen 
for Cys with a tenfold decrease in peak areas from pH 6 to pH 9, whereas sulfide shows the 
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least difference between the different pHs. Data are from 2 independent measurements. 
Inset, for GSH and sulfide the difference between groups was not significant. 1-way ANOVA 
p<0.01  Dunnet’s v. pH 7.4 (black bar) * p< 0.05. (B) NEM in ammonium phosphate buffer at 
each pH was added to fresh plasma samples. The percentual changes of peak area/internal 
standard area is presented relative to those at pH 7.4 (black bars), which was considered as 
a control group. Contrary to the analyses carried out in buffer (shown in panel A), the largest 
differences in measured peak areas were seen with sulfide, with large increases above pH 
7.4 as well as a slight increase at pH 6. Data are from 6 independent samples. For GSH, and 
HCys the differences among the groups were not significant. 1-way-ANOVA p<0.001;  
Dunnet’s v. pH 7.4 (black bar) * p< 0.05. 
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Figure 3 
 
 
Figure 3. Optimization of sample preparation procedure: anticoagulation, and 
stabilization with NEM. For all experiments depicted, NEM (or other thiol alkylating agent) 
was added directly to whole blood (panels A-D) after which the sample was centrifuged at 
800 x g for 10 min at room temperature. In panel E NEM was added to plasma directly after 
separation from blood cells by centrifugation of whole blood. (A) The choice of anticoagulant 
affects the concentrations of thiol measured; because of its metal chelating properties EDTA 
is the most suitable anticoagulant for assessment of the thiol redox metabolome. 2-way 
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ANOVA p<0.0019, Dunnet’s vs. ED A * p<0.01 (B) Delay in addition of NEM to whole blood 
leads to progressive decreases in GSH and CysGly concentrations as compared to time = 0. 
(C) The apparent concentrations of GSH and sulfide increase with increasing concentrations 
of NEM added to whole blood, as compared to whole blood treated with 1 mM NEM as a 
control (centrifugation 800 x g x 10 min). (D) The concentration of sulfide detected increases 
with increasing concentrations of alkylating agents added to whole blood. (E) The NEM 
concentration-dependent increases of GSH levels (as compared to samples treated with 1 
mM NEM) were not observed when NEM was added to plasma (although also absolute GSH 
concentrations were considerably lower), suggesting that these increases were largely due to 
leakage of GSH from blood cells; however, apparent plasma sulfide concentrations still 
increased with increasing NEM concentrations, suggesting removal of sulfide from bound 
forms in plasma at elevated concentrations of the alkylating agent. For all panels data were 
obtained by analysis of two independent biological samples taken form different human 
individuals (mean ± SD); measurements were carried out at least in duplicate. 
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Figure 4 
 
 
Figure 4: Optimization of sample preparation procedure: effects of centrifugation 
speed and duration, effects of freeze/thawing and sample stability. (A,B) NEM addition 
to whole blood (shown in A) increases stability of thiols in comparison to NEM addition to 
plasma (shown in B), as demonstrated by comparing overall absolute concentrations of the 
same thiols in A vs. B. However, when low speed/long duration centrifugation (800 x g, 10 
min) was chosen to separate plasma form blood cells this procedure artifically increases 
plasma GSH concentrations (shown in A, pink bar vs. blue bar), probably due to leakage of 
NEM-adducts form cellular blood components (RBCs); see main text. (C) Freezing of NEM 
stabilized plasma leads to an increase in GSH, Cys and CysGly concentrations compared to 
their levels in fresh samples; concentrations of GSH dramatically decreased, and GSSG 
increased when samples were frozen without stabilisation by NEM (n = 3; 2-way RM ANOVA 
p<0.001  Dunnet‘s vs. fresh plasma p<0.01). (D) In samples stabilized with NEM 
freeze/thawing or maintainance of samples in thermostatted autosampler at 5°C did not 
affect concentrations of the redox thiol metabolome (n = 3, differences among groups are not 
significant). For all panels 2 or 3 independent biological samples from different individuals 
were analysed; measurements were carried out in triplicates. 
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Figure 5 
 
Figure 5. Determination of the accuracy of the method (Method A) by comparison with 
an independent method optimized for GSH/GSSG detection (Method B) in plasma 
samples from 10 healthy human volunteers. In Method A detection of the thiol redox 
metabolome was carried out after ultrafiltration, separation on the Aqua UPLC column and 
detection by triple-quadrupole mass spectrometry. In Method B, thiols and disulfides were 
measured following deproteinization with sulfosalicylic acid, separation on a C18-UPLC 
column, and detection by Q-ToF mass spectrometry. (A) Concentrations of GSH are grossly 
underestimated by Method B, while Cys, HCys and HCysSS are overestimated by Method B 
compared to Method A (n = 10; 2-way RM ANOVA Method A vs.   p<0.0001  Sidak‘s 
multiple comparison test p<0.01; # T-Test-p<0.01). (B) Bland-Altman plots of the absolute 
differences in GSH and GSSG concentrations as assessed by Method A - Method B in 
relation to the mean values of the analytes. (C) Effects of freeze/thawing were absent when 
Method B (with SSA deproteinization) was used (n = 3). Both methods revealed very similar 
values when the same sample clearing/deproteinization procedures were applied (see also 
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Table 3). For all panels 3 to 10 independent biological samples were analysed; 
measurements were carried out in triplicates. 
. 
Figure 6 
Figure 6: Assessement of free, total and acid-labile thiols in human blood cells, urine 
and saliva.  (A) Workflow for determination of free (1), total (2) and acid-labile thiols (3) in 
biological samples such as blood plasma (Table 2), blood cells (panel B) and other biofluids 
(panels C,D). (B-D) For the determination of free, total and acid-labile thiols in blood cells 
(depicted in B), urine (shown in C) and saliva (shown in D), samples were divided into 3 
aliquots; one aliquot was used for determination of free thiols, one for total thiols following 
DTT reduction, and one for acid-labile thiols after addition of hydrochloric acid (HCl) and 
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subsequent neutralization by sodium hydroxide (NaOH). All measurements were carried out 
in triplicate. Data in B are means from individually analyzed cell pellets of the same 10 
volunteers of whom circulating plasma thiol concentrations were analyzed for inclusion in 
Tab. 2; data in panels C and D were from pooled saliva and urine samples of 5 healthy 
volunteers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 1 – The Thiol Redox Metabolome 
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Thiol, compound carrying an –SH group (generally from a cysteine).  
According to their molecular weight they are generally classified in (a) low 
molecular weight (LMW) thiols (e.g. cysteine, homocysteine, glutathione) and 
(b) high molecular weight thiols, which include protein thiols.   
According to their redox state they are classified as (a) reduced or “free” thiols 
(RSH), and (b) oxidized or “bound” thiols, where a thiol is bound to another thiol 
via a disulfide bridge including b1) symmetric disulfides (RSSR), where a 
disulfide bond links two equal molecules e.g. 2 cysteines to yield cystine, 2 
glutathione to give GSSG etc., or (c) mixed or asymmetric disulfides (RS-SP), 
carrying a disulfide bond between two different LMW thiols or a LMW thiol and 
a protein.   
According to the measurement protocol thiols are also classified in:  
(a) Free thiols, the concentration of thiols that are assessed in a specimen by 
derivatization with a thiol reactive reagent, like NEM, mBB, or IAM, for example. 
It may comprise (a1) LMW free thiols and (a2) (if proteins are not removed from 
the specimen before derivatization) protein free thiols + LMW thiols (which as 
sum are defined as total free thiols).  
(b) Total thiols (or DTT-reactive thiols), the concentration of all thiols that can be 
determined if a specimen is treated with a strong reducing agent such as DTT, 
which reduces disulfide bonds and liberates all oxidized bound thiols (RSSR, 
RSSP), and comprises free thiols (RSH) + oxidized / bound thiols (RSSR, 
RSSP).  
(c) Acid-labile thiols, the concentration of LMW thiols that is liberated from 
binding to proteins or sulfane sulfur compounds following the treatment of a 
biological sample with mineral acid (e.g. HCl); in the case of sulfide, this is 
known as “acid-labile sulfur” equivalents and originates from the decomposition 
of inorganic and organic persulfides and polysulfides. 
According to their concentrations, the thiols define: 
(a) the redox status of a tissue/cell, according to the ratio of reduced/oxidized 
thiols 
(b) the redox reserve (or total thiol status), which is an index of the total 
reducing capacity of a cell/tissue or organism that defines its resilience to 
oxidative modification.  
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Table 1: Structures, MS parameters, elution times and limits of detection (LOD) and 
quantification (LOQ) for the 12 analytes and 3 internal standards investigated. (n.d. - 
not determined) 
Analyte/Internal 
Standard 
 
Structures of Oxidised Thiols, 
NEM Derivatised Reduced 
Thiols and Sulfide 
Precur
sor Ion 
m/z 
Produ
ct Ion 
m/z 
Cone 
Energy / 
V 
Collision 
Energy 
/ V 
Elu
tio
n 
tim
e 
(C18
) 
/ 
mi
n 
Elu
tio
n 
tim
e 
(Aq
ua) 
/ 
mi
n 
L
O
D 
/ 
n
M 
 
L
O
Q 
/ 
n
M 
 
Reduced Thiols (NEM Derivatized) 
N-Acetlycysteine 
 
289.0 201.
0 
17 14 n.
d. 
4.0
5  
0.
5 
4 
Coenzyme A 
 
892.5 389.
0 
12 31 n.
d. 
n.
d. 
n.
d. 
n.
d. 
Cysteine 
 
247.1 158.
1 
8 18 2.1
8  
2.8
0 
8 2
0 
Cysteinyl-glycine 
 
304.0 212.
0 
8 8 2.3
0  
2.9
0 
2
0 
5
0 
Glutamyl-
cysteine 
 
376.0 246.
6 
5 10 1.8
0  
3.2
0  
0.
2 
0.
5 
Glutathione 
 
13C2,
15N 
Glutathione * 
 
 
433.1 
 
436.1 
304.
0 
 
307.
0 
 
6 
 
 
13 
 
 
2.0
0  
 
3.2
6  
0.
2 
0.
5 
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Homocysteine 
 
261.1 56.0 8 16 2.4
0  
3.0
8  
1 4 
Oxidized Thiols 
Cystine 
 
241.0 152 8 12 1.1
5  
1.1
0  
6
0 
1
0
0 
Glutathione 
(Oxidized) 
 
13C4,
15N2 
Glutathione 
(Oxidized)* 
 
 
613.0 
 
619.0 
355.
0 
 
361.
0 
 
10 
 
 
 
20 
 
 
 
1.0
0  
 
2.5
0  
0.
5 
2 
Homocystine 
 
269.1 136.
1 
14 4 1.2
0  
1.5
0  
4 7 
Sulfide Related Species (NEM Derivatized) 
Sulfide 
 
D10-NEM2-Sulfide 
 
285.1 
 
295.1 
160.
1 
 
165.
1 
 
8 
 
14 
 
4.8
5  
 
5.9
0 
4 8 
Persulfide 
 
317.0
  
160.
1 
8 14 5.5
0  
n.
d. 
n.
d. 
n.
d. 
Methanethiol 
 
173.6 74.6 1 11 n.
d. 
5.6
6 
5
0 
1
0
0 
 
 
 
Table 2: Free, total and bound concentrations of the 10 aminothiols and sulfide measured in 
human plasma from 10 individuals and the redox ratios of the key redox pairs. *The 
measured concentrations of CySS are not physiologically accurate due to poor peak 
shape and ion suppression. Columns 1 -10 show the mean ± SD of 3 technical replicate 
measures performed on plasma from 10 individuals. Outliers were identified by 
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applying the ROUT test, marked in italics, and excluded from descriptive statistics 
(mean ± SEM). 
    
1 2 3 4 5 6 7 8 9 10 
Mean ± 
SEM  
GSH 
Free / 
M 
6.34 
± 
0.04 
2.65 
± 
0.05 
1.40 
± 
0.02 
3.24 
± 
0.01 
6.36 
± 
0.11 
1.60 
± 
0.04 
2.26 
± 
0.04 
3.14 
± 
0.08 
6.25 
± 
0.23 
5.67 
± 
0.18 
3.89 ± 
0.65 
Total / 
M 
9.56 
± 
0.69 
7.33 
± 
0.94 
5.48 
± 
0.22 
9.49 
± 
0.32 
9.26 
± 
0.88 
5.69 
± 
0.38 
5.78 
± 
0.24 
6.75 
± 
0.47 
8.42 
± 
0.37 
8.35 
± 
0.45 
7.61 ± 
0.51 
Bound / 
M 
3.22 
± 
0.66 
4.68 
± 
0.97 
4.07 
± 
0.21 
6.24 
± 
0.32 
2.90 
± 
0.98
  
4.09 
± 
0.35 
3.52 
± 
0.23 
3.61 
± 
0.39 
2.17 
± 
0.18
  
2.69 
± 
0.48
  
3.72 ± 
0.36 
GSSG 
Free / 
nM 
7.17 
± 
0.34 
31.8
6 ± 
2.55 
6.01 
± 
0.40 
9.76 
± 
0.91 
6.24 
± 
0.89 
26.4
1 ± 
2.24 
6.86 
± 
0.81 
5.00 
± 
0.57 
7.89 
± 
0.53 
7.80 
± 
0.59 
7.09± 
0.51 
GSH/GS
SG 
Redox 
Ratio 
884  83 234 332 
102
0 
61 329 628 792  726  
509 ± 
109 
Cys 
Free / 
M 
15.9
8 ± 
0.54 
22.3 
± 
1.46 
10.8
1 ± 
0.47 
17.7
2 ± 
0.46 
15.1
4 ± 
1.15 
12.6
5 ± 
0.71 
15.4
2 ± 
0.62 
13.5
0 ± 
0.44 
9.81 
± 
0.34 
11.2
8 ± 
0.28 
14.46 ± 
1.18 
Total / 
M 
210.
01 ± 
26.9
6 
198.
81 ± 
13.2
5 
188.
68 ± 
1.82 
177.
75 ± 
5.52 
195.
03 ± 
4.37 
242.
2 ± 
8.76 
155.
08 ± 
0.48 
215.
78 ± 
11.3
1 
125.
86 ± 
12.1
0 
168.
66 ± 
10.7
3 
187.8 ± 
10.43 
Bound / 
M 
194.
03 ± 
27.4
8 
178.
59 ± 
22.7
1 
177.
87 ± 
1.66 
160.
02 ± 
5.46 
179.
9 ± 
5.45 
229.
55 ± 
8.20 
139.
66 ± 
0.79 
202.
28 ± 
10.8
8 
116.
04 ± 
11.8
3 
157.
39 ± 
11.0
0 
173.5 ± 
32.26 
CySS* 
Free / 
M 
*14.
90 ± 
0.69 
*15.
10 ± 
0.34
  
*11.
42 ± 
0.05 
*12.
45 ± 
0.43 
*13.
22 ± 
0.32 
*19.
96 ± 
5.28 
*9.0
6 ± 
0.27 
*14.
78 ± 
0.63 
*10.
59 ± 
0.69 
*12.
22 ± 
0.49 
*13.37 ± 
0.96 
Cys/CyS
S* 
Redox 
Ratio 
*1.0
7  
*1.4
8 
*0.9
5 
*1.4
2 
*1.1
5 
*0.6
3 
*1.7
0 
*0.9
1 
*0.9
3 
*0.9
2 
*1.12 ± 
0.10 
Hcys 
Free / 
M 
0.15 
± 
0.00
2 
0.24 
± 
0.00
4 
0.13 
± 
0.00
5 
0.17 
± 
0.00
5 
0.17 
± 
0.00
5 
0.14 
± 
0.00
6 
0.14 
± 
0.00
3 
0.07 
± 
0.00
1 
0.12 
± 
0.00
4 
0.13 
± 
0.00
2 
0.15 ± 
0.01 
Total / 
M 
8.62 
± 
0.49 
5.47 
± 
0.46 
5.21 
± 
0.17 
7.81 
± 
0.21 
5.65 
± 
0.21 
9.59 
± 
0.33 
6.02 
± 
0.42 
6.37 
± 
0.09 
4.40 
± 
0.57 
7.95 
± 
1.31 
6.71 ± 
0.53 
Bound / 
M 
8.47 
± 
0.49 
5.23 
± 
0.45 
5.08 
± 
0.16 
7.64 
± 
0.21 
5.48 
± 
0.21 
9.45 
± 
0.34 
5.88 
± 
0.42 
6.29 
± 
0.09 
4.29 
± 
0.57 
7.82 
± 
1.31 
6.56 ± 
0.53 
HcySS 
Free / 
nM 
18.9
5 ± 
0.78 
15.9
2 ± 
1.44 
9.72 
± 
3.54 
22.0
8 ± 
1.16 
11.3
9 ± 
0.74 
29.0
8 ± 
11.0
8 
11.7 
± 
1.39 
5.94 
± 
2.32 
13.0
0 ± 
2.01 
14.2
2 ± 
1.15 
15.2 ± 
2.12 
Hcys/H Redox 8.05 15.3 13.0 7.54 14.8 4.64 11.7 12.1 8.95 8.86 10.52 ± 
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cySS Ratio 6 6 4 6 5 1.09 
Sulfide 
Free / 
M 
0.27 
± 
0.02
0 
0.29 
± 
0.01
6 
0.03 
± 
0.00
1 
0.28 
± 
0.00
5 
0.05 
± 
0.00
1 
0.22 
± 
0.01
7 
0.30 
± 
0.01
3 
0.06 
± 
0.01
0 
0.11 
± 
0.01
1 
0.04 
± 
0.00
1 
0.17 ± 
0.04 
Total / 
M 
15.8
2 ± 
3.78 
15.8
3 ± 
3.34 
16.5
0 ± 
2.92 
15.4
5 ± 
0.98 
12.6
6 ± 
3.73 
16.0
9 ± 
1.75 
17.8
2 ± 
0.60 
16.3
5 ± 
2.30 
17.9
0 ± 
1.85 
19.5
5 ± 
3.12 
16.4 ± 
0.58 
Bound / 
M 
15.5
5 ± 
3.77 
15.5
4 ± 
3.35 
16.4
6 ± 
2.92 
15.1
6 ± 
0.99 
12.6
0 ± 
3.73 
15.8
7 ± 
1.76 
17.5
2 ± 
0.60 
16.2
9 ± 
2.29 
17.7
9 ± 
1.84 
19.5
1 ± 
3.12 
16.23 ± 
0.58 
Cys-gly 
Free / 
M 
1.47 
± 
0.08 
1.74 
± 
0.10 
1.12 
± 
0.01 
1.63 
± 
0.06 
1.91 
± 
0.05 
1.65 
± 
0.05 
1.41 
± 
0.02 
1.35 
± 
0.02 
1.64 
± 
0.01 
1.02 
± 
0.05 
1.49 ± 
0.09 
Total / 
M 
27.3
8 ± 
0.96 
29.7
5 ± 
0.42 
24.2
8 ± 
0.37 
28.6
6 ± 
0.48 
34.1
3 ± 
1.08 
41.1
5 ± 
1.18 
28.3
1 ± 
1.20 
29.1
1 ± 
0.18 
19.6
1 ± 
0.54 
26.3
1 ± 
0.60 
28.87 ± 
1.81 
Bound / 
M 
25.9
1 ± 
0.94 
28.0
1 ± 
0.48 
23.1
6 ± 
0.37 
27.0
3 ± 
0.51 
32.2
2 ± 
1.04 
39.5
0 ± 
1.22 
26.9
0 ± 
1.18 
27.7
7 ± 
0.20 
17.9
7 ± 
0.53 
25.2
9 ± 
0.55 
27.38 ± 
1.78 
Glu-cys 
Free / 
M 
0.07 
± 
0.00
1 
0.09 
± 
0.00
3 
0.05 
± 
0.00
1 
0.09 
± 
0.00
1 
0.08 
± 
0.00
2 
0.08 
± 
0.00
3 
0.07 
± 
0.00
4 
0.07 
± 
0.00
1 
0.05 
± 
0.00
2 
0.08 
± 
0.00
2 
0.08 ± 
0.004 
Total / 
M 
3.30 
± 
0.21 
2.62 
± 
0.32 
2.01 
± 
0.41 
3.02 
± 
0.60 
3.17 
± 
0.82 
3.18 
± 
0.10 
2.52 
± 
0.11 
2.34 
± 
0.57 
1.33 
± 
0.23 
2.69 
± 
0.29 
2.62 ± 
0.19 
Bound / 
M 
3.23 
± 
0.21 
2.53 
± 
0.33 
1.96 
± 
0.41 
2.93 
± 
0.61 
3.10 
± 
0.82 
3.10 
± 
0.10 
2.46 
± 
0.12 
2.27 
± 
0.57 
1.28 
± 
0.23 
2.61 
± 
0.29 
2.55 ± 
0.19 
NAC 
Free / 
nM 
4.23 
± 
0.30 
5.48 
± 
0.87 
5.23 
± 
0.15 
4.40 
± 
0.32 
8.50 
± 
0.12 
4.69 
± 
0.38 
4.47 
± 
0.18 
5.12 
± 
0.89 
9.1 
± 
0.07 
95.1
0 ± 
2.42 
5.69 ± 
0.61 
Total / 
nM 
428.
94 ± 
10.4
8 
35.0
4 ± 
1.47 
34.8
2 ± 
0.79 
36.3
2 ± 
1.37 
31.3
4 ± 
1.22 
34.7
1 ± 
1.79 
36.4
9 ± 
2.08 
42.7
7 ± 
1.82 
36.6 
± 
2.69 
512.
7 ± 
5.27 
36.01 ± 
1.14 
Bound / 
nM 
424.
71 ± 
10.7
7 
29.5
6 ± 
0.70 
29.5
9 ± 
0.91 
31.9
2 ± 
1.07 
22.8
5 ± 
1.12 
30.0
2 ± 
2.06 
32.0
2 ± 
1.93 
37.6
5 ± 
2.21 
27.5
1 ± 
2.67 
417.
6 ± 
6.67 
30.14 ± 
1.49 
 
 
 
Table 3: Comparison of deproteinization procedure with sulfosalicylic acid and 
clearance by ultrafiltration as assessed after separation on an Aqua-UPLC column and 
detection by triple-quadrupole mass-spectrometry in one biological sample . SSA – 
58 
 
sulfosalicylic acid; NEM - N-ethylmaleimide. All values show the mean ± SD of three 
technical replicates of a pooled plasma sample. 
 
 GSH 
[nM] 
Cys 
[nM] 
Hcys 
[nM] 
Sulfide 
[nM] 
SSA 753.3 ± 
89.0 
646.2 ± 
101.0 
10.4 ±  
1.4 
189.2 ± 
20.5 
SSA + NEM 750.4 ± 
93.6 
660.5 ± 
110.2 
11.3 ±  
1.9 
201.2 ± 
23.4 
Ultrafiltration 652.8 ± 
7.4 
1434.7 ± 
24.0 
54.3 ±  
2.1 
251.0 ± 
23.1 
 
Highlights 
 The thiol redox metabolome comprises free and bound thiols, disulfides, and sulfide 
 We developed a LC-MS/MS platform for detection of the thiol redox metabolome in 
biological samples 
 Thiols in blood, urine and saliva are stabilized by derivatization with N-
ethylmaleimide, also preventing oxidation 
 Total and acid-labile thiols are determined following addition of DTT and acid 
 Accuracy was investigated by comparison with an established method to assess GSH 
and GSSG  
 Applicability was shown for plasma of 10 healthy volunteers, blood cells, urine and 
saliva  
 
 
 
 
